curriculum vitae laurel c. preheim, m.d. mailing … · mailing address: office ... 1982 dl...
TRANSCRIPT
1
CURRICULUM VITAE LAUREL C. PREHEIM, M.D. MAILING ADDRESS: Office Home Department of Internal Medicine 1723 South 87th Street
Creighton University Medical Center Omaha, NE 68124 7710 Mercy Road – Suite 301 Omaha, Nebraska 68124-2354
PHONE: (402) 280-5923 (402) 393-2462 e-mail: [email protected] [email protected]; EDUCATION AND DEGREES:
Undergraduate: Bethel College, N. Newton, Kansas; B.A., 1969 Medical School: Northwestern University Medical School, Chicago, Illinois; M.D., 1973
POST GRADUATE MEDICAL TRAINING:
Internal Medicine Residency at Medical College of Wisconsin, Milwaukee, Wisconsin, 1973-76
(Daniel J. McCarty, Chairman) Infectious Diseases Fellowship at Medical College of Wisconsin, Milwaukee, Wisconsin, 1976-78
(Michael W. Rytel, Director) Post-Doctoral Research Fellowship in Department of Microbiology, St. Thomas' Hospital, London,
England, 1/1989-7/1989 (Barry Cookson, Preceptor; Ian Phillips, Chairman) Visiting Scientist, DNA Laboratory, National Collection of Type Cultures, Central Public Health
Laboratory, London, England, 2/1989-3/1989 (L. Roland Hill, Curator) Health Care Leadership Institute, Department of Veterans Affairs, Washington, DC, 2001 AAIM-MERCK Executive Leadership Program, Boston, MA, 2004
PROFESSIONAL CERTIFICATION: National Board of Medical Examiners, 1973 American Board of Internal Medicine, 1976 American Board of Internal Medicine (Infectious Diseases), 1980
PROFESSIONAL MEMBERSHIPS:
American College of Physicians (Fellow) Metropolitan Omaha Medical Society American Medical Association Nebraska Medical Association American Society for Microbiology Society for Healthcare Epidemiology Association of Professors of Medicine of America Veterans Affairs Society of Physicians in Infectious Diseases Association of Subspecialty Professors Infectious Diseases Society of America (Fellow)
MEDICAL LICENSURES:
Nebraska (14662) Wisconsin (18909)
2
HONORS: Alpha Omega Alpha, 1987 Visiting Professor, Infectious Disease Association of Thailand, Cheng Mei University, Khon Kaen
University, Hat Yai University, and Prince of Songkla University, September, 1985 Nominee, Golden Apple Teaching Award, Creighton University School of Medicine, 1986, 1992 Visiting Professor, United Medical and Dental Schools of Guy's and St. Thomas's Hospitals,
University of London, London, England, Jan-July, 1989 Best Doctors in America. Best Doctors, Inc.: 1996 - present Laureate Award, American College of Physicians, Nebraska Chapter, 1997 Who’s Who Among America’s Teachers, 2002 Guide to America’s Top Physicians, 2003 Evergreen Award (to Nebraska Chapter), American College of Physicians 2003, 2004 Distinguished Alumnus Award, Bethel College, N. Newton, KS, 2011
PROFESSIONAL APPOINTMENTS: Chief, Medicine Department 2004-10 Nebraska-Western Iowa VA Healthcare System Associate Chair, Department of Medicine 1998-10 Creighton University School of Medicine Associate Chief, Medicine Department, Omaha VAMC 1998-03
Chief, Creighton-University of Nebraska Section of Infectious Diseases 1992-98 Chief, Infectious Diseases Section 1992-98 University of Nebraska College of Medicine Department of Internal Medicine University of Nebraska Medical Center Chief, Infectious Diseases Section 1980-04 Department of Medical Microbiology and Immunology Department of Medicine Creighton University School of Medicine Director, Adult Infectious Diseases Fellowship Program 1980-96 Creighton University School of Medicine Chief, Infectious Diseases Section 1978-04 Omaha Department of Veterans Affairs Medical Center Professor of Internal Medicine 1992 University of Nebraska College of Medicine Professor of Medical Microbiology and Immunology 1991 Professor of Medicine Creighton University School of Medicine Associate Professor of Medical Microbiology and Immunology 1986-91 Associate Professor of Medicine Creighton University School of Medicine Epidemiologist 1979-88 Omaha Department of Veterans Affairs Medical Center
3
PROFESSIONAL APPOINTMENTS: (continued) Assistant Professor of Medical Microbiology and Immunology 1978-85 Assistant Professor of Medicine Creighton University School of Medicine Staff Physician:
St. Joseph Hospital/Creighton University Medical Center, Omaha, NE 1978- Department of Veterans Affairs Medical Center, Omaha, NE 1978- Douglas County Travelers' Clinic, Omaha, NE 1985-12 University of Nebraska Medical Center, Omaha, NE 1992- Bergan Mercy Hospital, Omaha, NE 1994- Alegent/Creighton Travel Clinic 2012-
PROFESSIONAL ACTIVITIES: Creighton University School of Medicine, Omaha, Nebraska: Department of Medicine Associate Chairs Committee 1998-10
Department of Medicine Service Chiefs Committee 1980-10 Academic Council 1982-84; 86-88 Committee on Continuing Education 1983-86 Graduate Education Committee, Department of Medicine 1984-98 Creighton University Speakers Bureau 1986- Committee on Student Research and Scholarly Activity 1989-92 Committee on Health Sciences Research 1990-92 Committee on Leaves and Sabbaticals 1990-92 Chairman, Department of Psychiatry Chair Search Committee 1992-93 LCME Self-Study Task Force
Member, Steering Committee 1996 Chair, Committee Task Force on CME 1996
Curriculum Systems Committee (Coordinator: Infectious Diseases) 1996-04 Department of Medicine Research Advisory Committee 1996-06 Course Director, Infectious Diseases System Course (IDC 233) 1997-04; 12-16
Task Force on Strategic Planning for Omaha VAMC Medicine 1998 Cancer and Smoking Disease Research Program Advisory Committee 1998-01 MBM Research and Design Team 1999-00 Department of Medicine Heme-Onc Chief Recruiting Committee 1999-00 Dean’s Executive Oversight Committee 2002-04 Department of Medicine Chair Search Committee 2005-06 Director, Antimicrobial Stewardship Program 2011-13
University of Nebraska Medical Center, Omaha, Nebraska:
Chairman, Department of Psychiatry Chair Search Committee 1992-93 Curriculum Revision Committee (Core 7 Planning Committee) 1992-93 Department of Medicine Service Chiefs Committee 1992-98 University of Nebraska Medical Center Speakers Bureau 1992- Therapeutic Agents Committee 1995-98
Omaha Department of Veterans Affairs Medical Center:
Infection Control Committee Chairman 1979-88 Member 1989-
Research and Development Committee 1980-82 Antibiotic Audit Subcommittee 1981-85 Pharmacy and Therapeutic Agents Committee 1981-03
4
PROFESSIONAL ACTIVITIES: (continued) Deans’ Committee 1998-10 Medical Staff Executive Committee 1998-10 Executive Council 1998-10 Service Chiefs Committee 1998-10 Ambulatory Care Council, Chairman 1998-00 Space Committee 1998-04 Resource Committee 1998-99 Omaha VAMC/Thomas Fitzgerald Veterans Home Collaboration Committee 1998-00 Chief of Staff Search Committee (Chair) 2002 Operations Committee 2004-08 New Medical Center Design Leadership Team 2010-12 Director, Antimicrobial Stewardship Program 2011-13
VISN 14 (Veterans Integrated Service Network) Primary/Specialty Care Service Line Leadership Council 2000-02 Chair, Chronic Lung Disease Management Committee 2000-02 VISN 23 Primary & Specialty Medicine Service Line Leadership Council 2002-10 Physicians Leadership Group, P & SM SL 2002-10 Utilization Review Committee, P & SM SL 2004-09 Saint Joseph Hospital/Creighton University Medical Center, Omaha, Nebraska:
Infection Control Committee 1981-82; 84- 87 Antimicrobial Utilization Committee 1984-85 Oncology Committee 1985-86 Quality Coordinating Council 1987-88 Drug Surveillance Committee 1990-91 Therapeutics Agents Committee 1994-95 Director, Antimicrobial Stewardship Program 2011-13
Metropolitan Omaha Medical Society:
AIDS Advisory Task Force, Omaha, Nebraska 1985-88 Bioterrorism Preparedness Advisory Task Force 2002-04
Alternate Delegate to the NMA House of Delegates 2008-10 American College of Physicians Nebraska Chapter: Governor 2000-04 Governor Elect 1999-00
Governor’s Advisory Council 1987-92; 96-08 ACP/Chapter Education Liaison 1996-97 Program Planning Committee Chair 1996-97
Member 1998-04 Nominations and Awards Committee Chair 2004-07
National Board of Governors 2000-04 Vice Chair Education Committee 2000-02 Infectious Diseases Society of America
Infectious Diseases/Internal Medicine Training Program Directors Committee 1998-02 Task Force: Training Requirements for Infectious Diseases Fellows 2002-03
5
PROFESSIONAL ACTIVITIES: (continued) Editorial Board, Infectious Disease Practice 1991-03 Editorial Advisory Board, MDConsult Infectious Disease 2001-04 Ad hoc Reviewer, Department of Veterans Affairs Merit Review Board 1985-00 Nebraska Department of Health and Human Services Advisory Committee for Bioterrorism Preparedness 2002-04 Manuscript Reviewer:
Addiction Biology Drugs & Aging American Journal of Epidemiology Infections in Urology American Journal of Gastroenterology Infection Control and Hospital Epidemiology Annals of Internal Medicine Journal of Antimicrobial Chemotherapy Antimicrobial Agents and Chemotherapy Journal of Leukocyte Biology Canadian Journal of Physiology and Pharmacology Nebraska State Medical Journal Clinical Infectious Diseases Survey of Digestive Diseases Clinical Toxicology Experimental Lung Research
Consultant: Abbott Laboratories, Anti-Infectives Research Division, 1990 Bureau on Issues in Infection Management, 1993
Community Service Countryside Community Church, Omaha, NE Chancel Choir 1980- Board of Deacons 1986-90 Volunteer Physician, Homeless Veterans Stand Down Outreach 1998-2010 FUNDED RESEARCH PROGRAMS EXTRAMURAL: FEDERAL 1978 LC Preheim (PI): Role of Immune Complexes in the Pathogenesis of Pneumococcal Infections.
Veterans Administration RRAG 1980 LC Preheim (PI): Role of Circulating Immune Complexes in the Pathogenesis of Pneumococcal
Infections. Veterans Administration Merit Review 1985 LC Preheim (Co-PI), MA Mellencamp (Co-PI): Effect of Cirrhosis on the Pathogenesis of
Pneumococcal Pneumonia. Veterans Administration Merit Review 1988 LC Preheim (Co-PI), MA Mellencamp (Co-PI): Effects of Cirrhosis on the Pathogenesis of
Pneumococcal Pneumonia. Veterans Administration Merit Review 1992 LC Preheim (PI): Effect of Cirrhosis on Pathogenesis of Pneumococcal Infection. Dept. of
Veterans Affairs Merit Review 1998 LC Preheim (Co-PI), MJ Gentry (Co-PI): Effect of Cirrhosis on the Pathogenesis of
Pneumococcal Infection. Dept. of Veterans Affairs Merit Review 2000 LC Preheim (Co-PI), MJ Gentry (Co-PI): Enhancement of Pneumococcal Pathogenesis in
Cirrhotic Hosts. Dept. of Veterans Affairs Merit Review
6
FUNDED RESEARCH PROGRAMS: (continued) EXTRAMURAL: INDUSTRIAL 1979 LC Preheim (PI): Comparison of LY 127935 and Gentamicin in the Treatment of Hospitalized
Patients with Urinary Tract Infections. Eli Lilly Company 1980 DL Dworzack (PI), LC Preheim (Co-I): Efficacy of RO 13-9904 in the Parenteral Therapy of
Serious Bacterial Infections. Hoffman LaRoche Inc. 1981 LC Preheim (PI): An Experimental Model for Induction and Treatment of Aspiration Pneumonia.
Eli Lilly Company 1981 MJ Bittner (PI), LC Preheim (Co-I): Comparison of Ceftriaxone and Cefamandole in the Therapy
of Pneumonia. Hoffman LaRoche Inc. 1981 LC Preheim (PI): Comparison of Cefoperazone and Cefotaxime in the Therapy of Serious
Bacterial Infections. Hoechst-Roussel Inc. 1982 DL Dworzack (PI), LC Preheim (Co-I): Tolerance to a Four-week Intra-nasal Application of
IFN-alpha2, IFN-alpha2 with Thimerosol, IFN-alpha2, with Benzyl Alcohol/Chlorobutanol, and Placebo. Schering Corporation
1982 LC Preheim (PI): Comparison of Moxalactam and Ceftazidime in the Therapy of Complicated
Urinary Tract Infections. Glaxo Inc. 1983 MJ Bittner (PI), LC Preheim (Co-I): Ceftriaxone versus Cefotaxime in the Parenteral Therapy of
Respiratory Tract Infections. Hoffman LaRoche Inc. 1984 LC Preheim (PI): Open Study of Ciprofloxacin and Double-Blind Comparison with Bactrim in
Treatment of Complicated Urinary Tract Infections. Miles Laboratories 1984 LC Preheim (PI): Randomized Comparison of Ciprofloxacin and Ceftriaxone in the Therapy of
osteomyelitis. Miles Laboratories 1986 LC Preheim (PI): Comparison of Ampicillin and Ciprofloxacin in the Treatment of Enterococcal
Urinary Tract Infections. Miles Laboratories 1987 MJ Bittner (PI), LC Preheim (Co-I): Comparison of the Efficacy and Safety of Sch 39720 and
Cefaclor in the Treatment of Acute Lower Respiratory Tract Infection. Schering Corporation 1987 LC Preheim (PI): Studies of Pseudomonas pseudomallei toxin production. ER Squibb & Sons,
Inc.; Merck Sharp & Dohme 1988 LC Preheim (PI): Studies of Pseudomonas pseudomallei susceptibility patterns and resistance.
Abbott Laboratories; Hoechst-Roussel Pharmaceuticals, Inc.; American Cyanamid Company; Glaxo Inc.; The Upjohn Company
1988 MJ Bittner (PI), LC Preheim (Co-I): A multicentric, open-label, randomized study to evaluate the
safety and efficacy of oral ofloxacin versus standard antimicrobial therapy in the treatment of pneumonia. Ortho Pharmaceuticals
1988 LC Preheim (PI): Multicentric open-label study to evaluate the safety and efficacy of parenteral
ofloxacin in the treatment of skin and skin structure infections in adults. Ortho Pharmaceuticals
7
FUNDED RESEARCH PROGRAMS: (continued) 1988 LC Preheim (PI): A comparative study of cefepime dihydrochloride/arginine (500 mg bid) versus
ceftazidime (500 mg bid) in the treatment of patients with urinary tract infections. Bristol-Myers Company
1991 LC Preheim (PI), MJ Bittner (Co-I): Comparison of oral temafloxan versus intravenous imipenem
in the treatment of patients with serious skin and soft tissue infections. Abbott Laboratories 1992 MJ Gentry (PI), LC Preheim (Co-I): Immunogenicity and efficacy of protein conjugated
pneumococcal polysaccharides in ethanol-fed and cirrhotic rats. Lederle-Praxis Biologicals 1992 LC Preheim (PI), PD Lister (Co-I): Effectiveness of G-CSF in the treatment of pneumococcal
pneumonia in a rat model of chronic intoxication. Amgen Corporation 1993 LC Preheim (Co-PI), TM McCashland (Co-PI): Response to Pneumococcal Vaccine in Chronic
Liver Disease. Merck & Co., Inc. 1994 LC Preheim (PI), MJ Gentry (Co-PI): Effectiveness of GM-CSF in protection against
pneumococcal pneumonia in a rat model of cirrhosis. Immunex Research and Development Corporation
1994 LC Preheim (PI), MJ Gentry (Co-PI): Effectiveness of G-CSF in protection against pneumococcal
pneumonia in a rat model of cirrhosis. Amgen Corporation 1996 LC Preheim (PI), MJ Gentry (Co-PI): Comparison of trovafloxacin and ceftriaxone for the
treatmetn of pneumococcal pneumonia in a rat model. Pfizer, Inc. 1997 LC Preheim (PI), MJ Gentry (Co-PI): Comparison of parenteral azithromycin and ceftriaxone for
the treatment of pneumococcal pneumonia in a rat model. Pfizer, Inc. 1997 LC Preheim (PI), MJ Gentry (Co-PI): Study of liposomal ciprofloxacin in a rat model of
pneumococcal pneumonia. Sequus Pharmaceuticals, Inc. 1998 LC Preheim (PI), MJ Gentry (Co-PI): Comparison of BAY 12-8039 and levofloxacin for the
treatment of pneumococcal pneumonia in a rat model. Bayer Corporation 1998 LC Preheim (PI), MJ Gentry (Co-PI): Comparison of trovafloxacin and levofloxacin for the
treatment of pneumococcal pneumonia in a rat model. Pfizer, Inc. 1999 MJ Gentry (PI), LC Preheim (Co-PI): Comparison of linezolid and ceftriazone for the treatment
of pneumococcal pneumonia in a rat model. Pharmacia Upjohn, Inc. 2006 LC Preheim (PI), MJ Gentry-Nielsen (Co-PI): Comparison of Daptomycin and Daptomycin
Derivative to Vancomycin and Linezolid in a Rat Model of MRSA Pneumonia. Cubist Pharmaceuticals
2007 LC Preheim (PI), MJ Gentry-Nielsen (Co-PI): Comparison of Tigecycline, Vancomycin and
Linezolid for the Treatment of Staphylococcal Pneumonia in a Rat Model. Wyeth Research
8
FUNDED RESEARCH PROGRAMS: (continued) INTRAMURAL: 1988 T Sookpranee (Co-PI), LC Preheim (Co-PI): In vitro effectiveness of new antimicrobial agents against
Pseudomonas pseudomallei. Biomedical Research Support Grant NIH/Creighton University 1989 M Sookpranee (Co-PI), LC Preheim (Co-PI): Antibiotic Combinations in Pseudomonas pseudomallei
Mouse Models. Biomedical Research Support Grant NIH/Creighton University 1989 CC Davis (Co-PI), LC Preheim (Co-PI): Effect of Ethanol on the Pathogenesis of Pneumococcal
Pneumonia. Biomedical Research Support Grant NIH/Creighton University 1989 PD Lister (Co-PI), LC Preheim (Co-PI): Mechanism of Impaired Serum Bacteriostasis by Cirrhosis.
Biomedical Research Support Grant NIH/Creighton University 1990 PD Lister (Co-PI), LC Preheim (Co-PI): Role of Ethanol in the Pathogenesis of Pneumococcal
Pneumonia. Biomedical Research Support Grant NIH/Creighton University 1993 LC Preheim (Co-PI), TM McCashland (Co-PI): Response to Pneumococcal Vaccine in Chronic Liver
Disease and Liver Transplantation. University of Nebraska Medical Center Seed Grant PUBLICATIONS: Papers 1. Preheim LC, Rytel M. Pneumococcal infection after vaccination. (letter) Lancet. 1978;2:1317. 2. Sanders CC, Sanders WE Jr., Dykstra MA, Preheim LC. LY 127935 A novel betalactam antibiotic.
Current Chemother. Infect. Dis. 1980;1:69-70. 3. Preheim LC, Sanders WE Jr. Nosocomial pneumonia. Comprehensive Therapy. 1980;7:20-7.
4. Penn RG, Knoop FC, Giger DK, Preheim LC. Plesiomonas shigeloides overgrowth in the small
intestine. J. Clin. Microbiology 1982;15:869-72. 5. Preheim LC, Penn RG, Sanders CC, Goering RV, Giger DK. Emergence of resistance to beta-lactam
and aminoglycoside antibiotic during moxalactam therapy of Pseudomonas aeruginosa infections. Antimicrob. Agents Chemother. 1982;22:1037-41.
6. Preheim LC. Nosocomial pneumonia. Postgraduate Microbiology. 1982;9:4-6.
7. Bittner MJ, Dworzack DL, Preheim LC, Tofte RW, Crossley KB. Ceftriaxone treatment of serious
bacterial infection in adults. Antimicrob. Agents Chemother. 1983;23:261-6. 8. Preheim LC, Bittner MJ, Haymond JD. Improving cephalosporin use with education and memoranda
reinforcement. In: Spitzy KH, Karrer K, eds. Proceedings of the 13th International Congress of Chemotherapy. Vienna. International Congress of Chemotherapy, 1983;73:38-41.
9. Bittner MJ, Preheim LC, Giger DK, Sanders WE Jr. Mycobacterium fortuitum sternotomy infections:
Correlation between susceptibility studies and serum cidal titers during therapy with amikacin, cefoxitin, and rifampin. In: Spitzy KH, Karrer K, eds. Proceedings of the 13th International Congress of Chemotherapy. Vienna. International Congress of Chemotherapy, 1983;66:43-6.
9
PUBLICATIONS: (continued)
10. Penn RG, Preheim LC, Sanders CC, Giger DK. Comparison of moxalactam and gentamicin in the
treatment of complicated urinary tract infections. Antimicrob. Agents Chemother. 1983;24:494-9. 11. Preheim LC. Lyme disease. Postgraduate Microbiology. 1984;11:1-3. 12. O'Donohue WJ, Bedi S, Bittner MJ, Preheim LC. Short-course chemotherapy for pulmonary infection
due to Mycobacterium bovis. Arch. Int. Med. 1985;145:703-5. 13. Delcore MG, Preheim LC. Cellulitis associated with dermatophyte infection in the vein-donor-leg of a
coronary artery bypass patient. Nebraska Medical Journal. 1985;70:113-5. 14. Horowitz EA, Preheim LC, Safranek TJ, Pugsley MP, Sanders CC, Bittner MJ. Randomized,
double-blind comparison of ceftazidime and moxalactam in complicated urinary tract infections. Antimicrob. Agents Chemother. 1985;28:299-301.
15. Preheim LC. Complicated urinary tract infections. Am J Med 1985;79(2A):62-6. 16. Rabinovitch RA, Koethe SM, Kalbfleisch J, Preheim LC, Rytel MW. Relationship between alternative
complement pathway activation, C-reactive protein, and pneumococcal infection. J Clin Microbiol 1986;23:56-61.
17. Rytel MW, Preheim LC. Antigen detection in the diagnosis and prognostic assessment of bacterial
pneumonias. Diagn Microbiol Infect Dis 1986;4:35S-46S. 18. Brittan JC, Preheim LC. Imported malaria: Problems with diagnosis and prevention. J Fam Pract
1986;22:451-2.
19. Preheim LC. Poster presenter's thumb. (letter) N Engl J Med 1986;314:1518. 20. Preheim LC, Cuevas TA, Roccaforte JS, Mellencamp MA, Bittner MJ. Ciprofloxacin and antacids.
(letter) Lancet. 1986;2:48. 21. Bittner MJ, Preheim LC, Pugsley MP, Horowitz EA, Strike DG, Sanders CC. Randomized comparison
of ceftriaxone and cefamandole therapy of respiratory tract infections in adults. J Antimicrob Chemother 1986;18:621-8.
22. Preheim LC, Rimland D, Bittner MJ. Methicillin-resistant Staphylococcus aureus in Veterans
Administration Medical Centers. Infect Control 1987;8:191-4. 23. Preheim LC, Cuevas TA, Roccaforte JS, Mellencamp MA, Bittner MJ. Oral ciprofloxacin for
complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria in elderly patients. Am J Med 1987;82(4A):295-300.
24. Gilbert DN, Tice AD, Marsh PK, Craven PC, Preheim LC. Oral ciprofloxacin therapy of chronic
contiguous osteomyelitis due to aerobic gram-negative bacilli. Am J Med 1987;82(4A):254-8. 25. Mellencamp MA, Preheim LC, McDonald TL. Isolation and characterization of circulating immune
complexes from patients with pneumococcal pneumonia. Infect Immun 1987;55:1737-42.
10
PUBLICATIONS: (continued)
26. Horowitz EA, Preheim LC, Safranek TJ, Pugsley MP, Sanders CC, Bittner MJ. Randomized,
double-blind comparison of ceftazidime and moxalactam in complicated urinary tract infections. In: SM Wolff, FP Tally, GT Keusch, MS Klempner, DR Snydman (eds.) The Year Book of Infectious Diseases. Chicago, Year Book Medical Publishers, 1987, pp. 49-50.
27. Preheim LC, Rimland D, Bittner MJ. Methicillin-resistant Staphylococcus aureus in Veterans
Administration Medical Centers. In: DE Rogers, RM Des Prez, MJ Cline, E Braunwald, NJ Greenberger, JD Wilson, FH Epstein, and SE Malawista (eds.). Year Book of Medicine. Chicago, Year Book Medical Publishers, 1988, pp. 51-4.
28. Roccaforte JS, Bittner MJ, Stumpf C, Preheim LC. Attempts to eradicate colonization with
methicillin-resistant Staphylococcus aureus using trimethoprim-sulfamethoxazole, rifampin, and bacitracin. Am J Infect Control 1988;16:141-6.
29. Allais JM, Preheim LC, Cuevas TA, Roccaforte JS, Mellencamp MA, Bittner MJ. Randomized,
double-blind comparison of ciprofloxacin and trimethoprim/sulfamethoxazole in complicated urinary tract infections. Antimicrob Agents Chemother 1988;32:1327-30.
30. Mellencamp MA, Roccaforte JS, Preheim LC, Sanders CC, Anene CA, Bittner MJ. Susceptibility of
Enterobacter aerogenes to -lactam antibiotics despite high level -lactamase production. Eur J Clin Microbiol Infect Dis 1990;9:827-30.
31. Mellencamp MA, Preheim LC. Pneumococcol pneumonia in a rat model of cirrhosis: Effects of
cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. J Infect Dis 1991;163:102-8.
32. Preheim LC. Poster presenter's thumb. In: Bennett HJ The Best of Medical Humor. A collection of
articles, essays, poetry, and letters published in the medical literature. Philadelphia, Hanley and Belfus, Inc.,1991, p. 110.
33. Sookpranee T, Sookpranee M, Mellencamp MA, Preheim LC. Pseudomonas pseudomallei: A
common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics. Antimicrob Agents Chemother 1991;35:484-9.
34. Davis CC, Mellencamp MA, Preheim LC. A model of pneumococcal pneumonia in chronically
intoxicated rats. J Infect Dis 1991;163:799-805. 35. Snitily MU, Gentry MJ, Mellencamp MA, Preheim LC. A simple method for collection of blood from
the rat foot. Lab Animal Sci 1991; 41:285-7. 36. Preheim L, Pitcher D, Owen R, Cookson B. Typing of methicillin-resistant and susceptible
Staphylococcus aureus strains by ribosomal RNA gene restriction patterns using a biotinylated probe. Eur J Clin Microbiol Infect Dis 1991;10:428-36.
37. Auten GM, Preheim LC, Sookpranee M, Bittner MJ, Sookpranee T, Vibhagool A. High pressure liquid
chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections. Antimicrob Agents Chemother 1991;35:2558-61.
38. Preheim LC, Gentry MJ, Snitily MU. Pulmonary recruitment, adherence, and chemotaxis of neutrophils
in a rat model of cirrhosis and pneumococcal pneumonia. J Infect Dis 1991;164:1203-6.
11
PUBLICATIONS: (continued) 39. Lentino JR, Preheim LC, Mellencamp MA, Dworzack DL. Oral ciprofloxacin versus parenteral
ceftriaxone therapy of osteomyelitis due to Staphylococcus aureus and other pathogens. In: Rubinstein E, ed. Proceedings of the 3rd International Symposium on New Quinolones. Vancouver. Eur J Clin Microbiol Infect Dis, 1991, pp. 411-2.
40. Preheim LC, Auten GM, Sookpranee M, Bittner MJ, Sookpranee T, Vibhagool A. Safety and efficacy
of ofloxacin therapy for skin and soft tissue infections in hospitalized adults. In: Rubinstein E, ed. Proceedings of the 3rd International Symposium on New Quinolones. Vancouver. Eur J Clin Microbiol Infect Dis, 1991, pp. 323-4.
41. Preheim LC. Infectious complications of alcoholism. Infect Dis Pract, 1992;16:1-7. 42. Horowitz EH, Preheim LC, Neumann TV, Bittner MJ. Hepatotoxicity due to amphotericin B. Infect Dis
Clin Pract 1992;1:123-5. 43. Lister PD, Mellencamp MA, Preheim LC. Serum-sensitive Escherichia coli multiply in cirrhotic serum.
J Lab Clin Med 1992;120:-633-8. 44. Preheim LC, Mellencamp MA, Snitily MU, Gentry MJ. Effect of cirrhosis on the production and efficacy
of pneumococcal capsular antibody in a rat model. Am Rev Respir Dis, 1992;146:1054-8. 45. Preheim LC. Pulmonary infiltrates in cancer patients. Infect Dis Pract 1993;17:1-5. 46. Boken DJ, Leoni PA, Preheim LC. Treatment of Strongyloides stercoralis hyperinfection syndrome with
thiabendazole administered per rectum. Clin Infect Dis 1993;16:123-6. 47. Lister PD, Gentry MJ, Preheim LC. Ethanol impairs neutrophil chemotaxis in vitro but not adherence
or recruitment to lungs in rats with experimental pneumococcal pneumonia. J Infect Dis 1993;167:1131-7.
48. Lister PD, Gentry MJ, Preheim LC. Granulocyte colony-stimulating factor protects control rats but not
ethanol-fed rats from fatal pneumococcal pneumonia. J Infect Dis 1993;168:922-6. 49. Boken DJ, Preheim LC. Urinary tract infection. Short course therapy. Infect Dis Pract 1994;18:57-60. 50. Gentry MJ, Snitily MU, Preheim LC. Phagocytosis of Streptococcus pneumoniae measured in vitro
and in vivo in a rat model of carbon tetrachloride-induced liver cirrhosis J Infect Dis 1995;171:350-5. 51. Hanson MN, Preheim LC, Chou S, Talarico CL, Biron KK, Erice A. Novel mutation in the UL97 gene
of a clinical cytomegalovirus strain conferring resistance to gancyclovir. Antimicrob Agents Chemother 1995;39:1204-5.
52. Preheim LC, Childs SJ, Rajfer J, Bittner MJ. Randomized, double-blind comparison of cefepime and
ceftazidime therapy for urinary tract infection. Curr Ther Res 1995; 56:729-37. 53. Jareo P, Preheim LC, Lister PD, Gentry MJ. The effect of ethanol ingestion on killing of Streptococcus
pneumoniae, Staphylococcus aureus, and Staphylococcus epidermidis by rat neutrophils. Alcohol Alcoholism 1995; 30:311-18.
54. Bittner MJ, Horowitz EA, Safranek TJ, Preheim LC. Emergence of Mycobacterium kansasii as the
leading mycobacterial pathogen over a 20-year period at a midwest Veterans Hospital with declining Mycobacterium tuberculosis. Clin Infect Dis 1996;22:1109-10.
12
PUBLICATIONS: (continued) 55. Gentry MJ, Snitily MU, Preheim LC. Decreased uptake and killing of Streptococcus pneumoniae within
the lungs of cirrhotic rats. Immunol Infect Dis 1996;6:43-7. 56. Preheim LC, Snitily MU, Gentry MJ. Effects of granulocyte colony-stimulating factor in cirrhotic rats
with pneumococcal pneumonia. J Infect Dis 1996;174:225-8. 57. Jareo PW, Preheim LC, Gentry MJ. Ethanol ingestion impairs neutrophil bactericidal mechanisms
against Streptococcus pneumoniae. Alcoholism Clin Exp Res 1996;20:1646-52. 58. Smith TL, Preheim LC. Scrofula: The king’s touch revisited. Infect Dis Practice 1997;21:1-3. 59. Barry JW, Dominguez EA, Boken DJ, Preheim LC. Hafnia alvei infections after liver transplantation.
Clin Infect Dis 1997;24:1263-4. 60. Jareo PW, Preheim LC, Snitily MU, Gentry MJ. Isolation of peripheral blood neutrophils from rats using
magnetic cell sorting. Lab Animal Sci 1997;47:414-418. 61. Preheim LC, Smith TL. Mycobacterial infections. New threats from old disease. Comprehensive
Therapy 1997;23:310-18. 62. Henriksen JL, Preheim LC, Gentry MJ. Vaccination with protein-conjugated and native type 3 capsular
polysaccharide in an ethanol-fed rat model of pneumococcal pneumonia. Alcoholism Clin Exp Res 1997;21:1630-7.
63. Preheim LC. Career opportunities for infectious diseases subspecialists. Clin Infect Dis 1998;26:277-
281. 64. Joiner KA, Powderly WG, Blaser MJ, Klempner MS, Locksley RM, Mandell GL, Preheim LC,
Remington JS, Slama TG, Steigbigel NH, Bartlett JG. Fellowship training in infectious diseases: a report from the regional and national meetings of infectious diseases division chiefs and program directors. Clin Infect Dis 1998;26:1060-5.
65. Ellbogen MH, Preheim LC. Lemierre’s syndrome: features of a classic infectious disease. Infect Dis
Practice 1999;23:1-3. 66. Preheim LC, Olsen KM, Yue M, Snitily MU, Gentry MJ. Ethanol feeding does not affect the efficacy or
pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia. Alcoholism Clin Exp Res 1999;23:842-849.
67. Alcantara RB, Preheim LC, Gentry MJ. The role of pneumolysin’s complement-activating activity
during pnuemococcal bacteremia in cirrhotic rats. Infect Immun 1999;67:2862-2866. 68. McCashland TM, Preheim LC, Gentry MJ. Pneumococcal vaccine response in cirrhosis and liver
transplantation. J Infect Dis 2000;181:757-60. 69. Gentry-Nielsen MJ, Preheim LC, Lyman KN, McDonough KH, Potter BJ. Use of rat models to mimic
alterations in iron homeostasis during human alcohol abuse and cirrhosis. Alcohol 2001;23:71-81. 70. Alcantara RB, Preheim LC, Gentry MJ. Pneumolysin-induced complement depletion during
experimental pneumococcal bacteremia. Infect Immun 2001;60:3569-3575. 71. Gentry-Nielsen MJ, Olsen KM, Preheim LC. The pharmacodynamic activity and efficacy of linezolid
in a rat model of pneumococcal pneumonia. Antimicrob Agents Chemother 2002;46:1345-51.
13
72. Ellbogen MH, Olsen KM, Gentry-Nielsen MJ, Preheim LC. Efficacy of liposome-encapsulated
ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia. J Antimicrob Chemother 2003;51:83-91.
73. Gentry-Nielsen MJ, Vander Top E, Snitily MU, Casey CA, Preheim LC. A rat model to determine the
biomedical consequences of concurrent ethanol ingestion and cigarette smoke exposure. Alcoholism Clin Exp Res 2004;28:1120-28.
74. Preheim LC, Olsen KM, Yue M, Snitily MU, Gentry-Nielsen MJ. Effect of cirrhosis on antibiotic efficacy
in a rat model of pneumococcal pneumonia. Diagnostic Microbiol Infect Dis 2005;51:103-11. 75. Olsen KM, Gentry-Nielsen MJ, Yue M, Snitily MU, Preheim LC. Effect of ethanol on the efficacy of
fluoroquinolone therapy in a rat model of pneumococcal pneumonia. Antimicrob Agents Chemother 2006;50:210-219.
76. Propst-Graham KL, Preheim LC, Vander Top EA, Snitily MU, Gentry-Nielsen MJ. Cirrhosis-induced
defects in innate pulmonary defenses against Streptococcus pneumoniae. BMC Microbiology 2007; 7:94-104.
77. Almeida NJ, Murthy MH, Preheim LC. Prosthetic knee joint infection caused by Campylobacter
gracilis. Infect Dis Clin Pract 2009;17:118-19.
78. Knaak E, Cavalieri SJ, Elasser GN, Preheim LC, Gonitzke A, Destache CJ. Does antibiotic de-escalation for nosocomial pneumonia impact intensive care unit length of stay? Infect Dis Clin Pract 2013;21:172-6.
79. Foral PA, Anthone JM, Destache CJ, Vivekanandan R, Preheim LC, Gorby GL, Horne JM, Dobronski
LA, Syed JJ, Mindru C, Ali MA, Ali KF, Neemann KA, Bittner MJ. Education and Communication in an Interprofessional Antimicrobial Stewardship Program. J Am Osteopath Assoc. 2016;116(9):588-593.
PUBLICATIONS: Books, Chapters, Monographs, Online Publications 1. Marr JJ, Liu C, Preheim LC, Lusk RM. The prevention of pneumococcal pneumonia in clinical practice:
A national symposia series. American Cyanamid Co., Wayne, N.J. 1981:1-11. 2. Preheim LC. Transtracheal aspiration. In: MW Rytel and W Mogabgab (eds.). Clinical Manual of
Infectious Diseases. Chicago, Year Book Medical Publishers, 1984, pp. 485-9. 3. Preheim LC. New infections: A potpourri. In: WE Sanders Jr (ed.). Infectious Diseases and Medical
Microbiology: A Postgraduate Supplement. Omaha, Creighton University School of Medicine, 1984, pp 7-14.
4. WE Sanders Jr and LC Preheim (eds): Infectious Diseases and Medical Microbiology: A Postgraduate
Supplement. Vol. 2. Omaha, Creighton University School of Medicine, 1988. 5. Preheim LC. Chronic mononucleosis syndrome. In: WE Sanders Jr and LC Preheim (eds). Infectious
Diseases and Medical Microbiology: A Postgraduate Supplement. Vol 2. Omaha, Creighton University School of Medicine, 1988, pp. 26-9.
6. Preheim LC. Summary of selected sexually transmitted disease treatment guidelines. In: WE Sanders,
Jr and LC Preheim (eds). Infectious Diseases and Medical Microbiology: A Postgraduate Supplement. Vol 2. Omaha, Creighton University School of Medicine, 1988, pp. 47-9.
14
PUBLICATIONS: Books, Chapters, Monographs, Online Publications (continued) 7. Preheim LC. Tuberculosis and other mycobacterial infections. In: Carlson RW and Gehab MA (eds).
The principles and practice of medical intensive care. Philadelphia, WB Saunders Co., 1993 p.422-33.
8. Dominguez EA, Rupp ME, Preheim LC. Fever without neutropenia. In Abeloff MD, Armitage JO,
Lichter AS, Niederhuber JE (eds.). Clinical oncology. New York, Churchill Livingstone. 1995, p.501-12.
9. Preheim LC. Other mycobacterioses. In: Bennett JC and Plum F (eds). Cecil textbook of medicine,
20th edition. Philadelphia, WB Saunders. 1996, p. 1690-91. 10. Preheim LC, Gentry MJ. Infection in the alcoholic. In: Schlossberg D (ed). Current therapy of infectious
disease. St. Louis, Mosby. 1996, p. 308-11. 11. Preheim LC, Gorby GL, Childs SJ. A focus on prostatitis. Audio forum. Scientific Exchange, Inc., 1997,
p. 1-26. 12. Preheim LC. Other non-tuberculous mycobacteria and Mycobacterium bovis. In: Schlossberg D (ed).
Tuberculosis and non-tuberculous mycobacterial infections. Orlando. WB Saunders. 1999, p. 398-405.
13. Gentry MJ, Preheim LC. Models of pneumonia in ethanol-treated rats. In: Zak O, Sande M (eds).
Handbook of animal models of infection. Academic Press. 1999, p. 501-507. 14. Preheim LC, Gorby GL, Gentry MJ. Pneumococcal pneumonia and bacteremia in a cirrhotic rat model.
In: Zak O, Sande M (eds). Handbook of animal models of infection. Academic Press. 1999, p. 509-515.
15. Preheim LC. Other mycobacterioses. In: Goldman L, Bennett JC (eds). Cecil textbook of medicine, 21st edition. Philadelphia, WB Saunders 2000, p 1731-33.
16. Dominguez EA, Rupp ME, Preheim LC. Fever in the patient without neutropenia. In Abeloff MD,
Armitage JO, Lichter AS, Niederhuber JE (eds.). Clinical oncology. New York, Churchill Livingstone, 2nd edition 2000, p 707-718.
17. Preheim LC, Gentry MJ, Yue M, Snitily MU, Olsen KM. Comparison of azithromycin, trovafloxacin, and ceftriaxone for pneumococcal pneumonia in ethanol-fed rats. In Zinner SH, Young LS, Acar JF, Ortiz-Neu C (eds). New considerations for macrolides, azalides, streptogramins, and ketolides. New York. Marcel Dekker, Inc. 2000, p 649-652.
18. Stalder TS, Preheim LC. Gram-positive bacteria. In: Mainous AG III, Pomeroy C (eds). Management
of antimicrobials in infectious diseases. Impact of antibiotic resistance. Totowa, NJ, Humana Press. 2000, p 29-41.
19. Preheim LC, Gentry MJ. Infection in the alcoholic. In: Schlossberg D (ed). Current therapy of infectious
disease, 2nd edition. St. Louis, Mosby. 2001, p 376-380. 20. Sharma A, Preheim L. Case report: Woman with a sore shoulder and substance abuse
[Perspectives, ID Rounds]. MD Consult Infectious Disease. April 17, 2002. Available at: http://www.mdconsult.com
15
PUBLICATIONS: Books, Chapters, Monographs, Online Publications (continued) 21. Nawab M, Preheim L. Case report: Man with nosocomial bacteremic pneumonia caused by a Gram-
positive rod [Perspectives, ID Rounds]. MD Consult Infectious Disease. January 3, 2003. Available at: http://www.mdconsult.com.
22. Preheim, L. Tuberculosis and non-tuberculous mycobacterial infections. In: Cunha, B (ed). Educational
Review Manual in Infectious Diseases. New York, Castle Connolly Graduate Medical Publishing. 2003.
23. Ayi BS, Rupp M, Preheim L. Case report: Man with fever, confusion, and a red hand. [Clinical Insights,
ID Rounds]. MD Consult Infectious Disease. July 15, 2003. Available at: http://www.mdconsult.com. 24. Preheim LC. Other mycobacterioses. In Goldman L and Ausiello D. Cecil Textbook of Medicine, 22nd
edition. Philidelphia, Elsevier. 2003, p 1902-4. 25. Slifer K, Dworzack D, Preheim L. Case report: Perplexing pyrexia n a man from Mexico. [Clinical
Insights, ID Rounds]. MD Consult Infectious Disease. September 5, 2003. Available at: http://www.mdconsult.com.
26. Andersen CI, Snow EA, Novak D, Hayes K, Preheim L. Disseminated cutaneous nodules in a diabetic
patient. [Case Studies]. Available at http://www.idreference.com. Companion web site for Cohen and Powderly: Infectious Diseases, 2nd Edition, Elsevier. November, 2005.
27. Preheim LC, Bittner MB. Other non-tuberculous mycobacteria and Mycobacterium bovis. In:
Schlossberg D (ed). Tuberculosis and non-tuberculous mycobacterial infections, 5th Edition. Orlando. WB Saunders. New York, McGraw-Hill. 2006, p 489-97.
28. Preheim LC. Infections in cirrhosis in the Critical Care Unit. In: Cunha BA (ed). Infectious Diseases
in Critical Care Medicine, 2nd Edition. Informa Healthcare USA, Inc., New York. 2008, p. 433-43. 29. Preheim LC, Nusair AR. Infection in the alcoholic. In: Schlossberg D (ed). Clinical Infectious Disease.
Cambridge University Press, New York. 2008, p. 637-642. 30. Bittner MJ, Preheim LC. Tuberculosis and nontuberculous mycobacterial infections. In: Cunha BA,
ed. Educational review manual in infectious diseases. 4th ed. New York: Castle Connolly Graduate Medical Publishing; 2009.
31. Preheim LC. Infections in cirrhosis in critical care. In: Cunha BA (ed). Infectious Diseases in Critical
Care Medicine, 3nd Edition. Informa Healthcare USA, Inc., New York. 2010, p. 341-49.
32. Preheim LC, Ali MA. Infection in the alcoholic. In: Schlossberg D (ed). Clinical Infectious Disease, Second Edition. Cambridge University Press, New York. 2015, p. 597-602.
33. Bittner MB, Preheim LC. Other slow-growing nontuberculous mycobacteria. Microbiol Spectrum 4
(5):TNM17-0012-2016.
16
PUBLICATIONS: Abstracts 1. Preheim LC, Schiffman G, Komorowski R, Rytel MW. Immune Complex nephritis associated with
pneumococcal infection. Clin Res 26:404A, 1978 National Meeting Amer Fed Clin Res, Infect Dis Section (San Francisco, CA) May, 1978.
2. Preheim LC, Schiffman G, Koethe S, Jordon R, Rytel MW. Significance of circulating immune
complexes in pneumococcal infections. Clin Res 26:718A, 1978. Central Soc for Clin Res, Infect Dis Section (Chicago, IL) November, 1978.
3. Crespo JH, Preheim LC, Rytel MW. Lung abscess in pneumococcal pneumonia. Clin. Res. 26:768A,
1978. Southern Section, Amer Fed Clin Res 1978. 4. Rytel MW, Preheim LC, Dee TH, Hussey C, Koethe S, Schiffman G. Disseminated intravascular
coagulation in pneumococcal sepsis. Clin Res 27:42A, 1979. Western Section. Amer Fed Clin Res Infect Dis Section, (Carmel, CA) February, 1979.
5. Preheim LC, Jordon R, Schiffman G, Rytel MW. Detection of circulating immune complexes in
pneumococcal infections. Clin Res 27:354A, 1979. National Meeting Amer Fed Clin Res, 1979. 6. Gotch EL, Baudo JA, Preheim LC. Epidemiology and control of nosocomial infections due to multiply
resistant Providencia stuartii. Proceedings of Advanced VA Infection Control Conf. (Salt Lake City, UT) p. 48, September, 1979.
7. Sanders CC, Sanders WE Jr, Dykstra MA, Preheim LC. LY 127935: A novel beta lactam. 19th
Interscience Conference on Antimicrobial Agents and Chemotherapy and 11th International Congress of Chemotherapy. (Boston, MA) Abstract No. 128, October, 1979.
8. Preheim LC, Schiffman G, Mailliard J, Schlueter W. Pneumococcal vaccine responses in chronic
lymphocytic leukemia and multiple myeloma. Clin Res 27:753A, 1979. 9. Penn RG, Preheim LC, Sanders CC, Sanders WE Jr. Comparison of moxalactam and gentamicin in
the treatment of hospitalized patients with acute urinary tract infections. 20th Interscience Conference on Antimicrobial Agents and Chemotherapy. (New Orleans, LA) Abstract No. 375, October 1980.
10. Preheim LC, Penn RG, Sanders CC, Goering RV. Emergence of resistance to moxalactam and
aminoglycosides with moxalactam therapy of Pseudomonas infections. 21st Interscience Conference on Antimicrobial Agents and Chemotherapy. (Chicago, IL) Abstract No. 729, November, 1981.
11. Preheim LC, McCracken GH Jr, Jubelirer OP, Sanders CC, Barrett FF. Moxalactam penetration into
brain abscess. 21st Inter-science Conference on Antimicrobial Agents and Chemotherapy. (Chicago, IL) Abstract No. 738, November, 1981.
12. Preheim LC, Penn RG, Sanders CC, Goering RV. Emergence of resistance to moxalactam and
aminoglycosides with moxalactam therapy of Pseudomonas infections. Pseudomonas Newsletter 6(4):6, December, 1981.
13. Bittner MJ, Dworzack DL, Preheim LC, Tofte RW, Crossley KB. Ceftriaxone (Ro 13-9904) treatment
of serious bacterial infections in adults 82nd Annual Meeting Amer Soc for Micro (Atlanta, GA) Abstract No. A6, March, 1982.
14. Warner JB, Preheim LC, Giger DK. Therapy of experimental Pseudomonas aeruginosa pneumonia in
rats. 82nd Annual Meeting Amer Soc Micro (Atlanta, GA) Abstract No. A60, March, 1982.
17
PUBLICATIONS: Abstracts (continued) 15. Giger DK, Preheim LC, Gotch EL. Bronchoscopy specimen contamination by Mycobacterium
gordonae from an oxygen delivery system. Abstracts of 9th Annual National Educational Conference of the Association for Practitioners in Infection Control, (New Orleans, LA) p. 42, May, 1982.
16. Preheim LC, Bittner MJ, Giger DK, Sanders WE Jr. Mycobacterium fortuitum sternotomy infections
treated with amikacin, cefoxitin and rifampin: Serum static and killing titers. 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. (Miami Beach, FL) Abstract No. 564, October, 1982.
17. Giger DK, Preheim LC, Gotch EL. Microbial contamination of oxygen humidifiers. 22nd Interscience
Conference on Antimicrobial Agents and Chemotherapy. (Miami Beach, FL) Abstract No. 925, October, 1982.
18. Preheim LC, Bittner MJ, Haymond JD. Modifying antibiotic use with an educational approach. Clin
Res 30:728A, 1982. Midwest Health Science Res Section, Amer Fed Clin Res, (Chicago, IL) November, 1982.
19. Warner JB, Preheim LC, Giger DK. A rat model for induction and therapy of combined Pseudomonas
aeruginosa and Bacteroides fragilis pneumonia. Abstract No B118, 83rd Annual Meeting Amer Soc for Micro, (New Orleans, LA) March, 1983.
20. Giger DK, Preheim LC, Bittner MJ, Sanders WE Jr. Mycobacterium fortuitum susceptibility testing:
variability between in vitro results and serum killing activity. 83rd Annual Meeting Amer Soc for Micro, (New Orleans, LA) Abstract No A60, March, 1983.
21. Dworzack DL, Pugsley MP, Preheim LC, Bittner MJ, Horowitz EA, Sanders WE Jr, Wettengel P.
Tolerance to intranasal recombinant leukocyte interferon. 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy. (Las Vegas, NV) Abstract No 385, October, 1983.
22. Rabinovitch RA, Koethe SM, Kalbfleisch J, Preheim LC, Rytel MW. Relationship between activation
of alternative pathway of complement, C-reactive protein, and severity of pneumococcal disease. Clin Res 31:736A, 1983. Midwest Infectious Disease Section, Amer Fed Clin Res, (Chicago, IL) November, 1983.
23. Bittner MJ, Preheim LC, Pugsley MP, Horowitz EA, Strike DG, Sanders CC. Randomized comparison
of ceftriaxone and cefamandole therapy of lower respiratory tract infections in adults. 84th Annual Meeting, American Society Microbiology. (St. Louis, MO) Abstract No A44, 1984.
24. Mellencamp MA, McDonald TL, Preheim LC. Circulating immune omplexes in patients with
pneumococcal infections. 84th Annual Meeting American Society for Microbiology, (St. Louis, MO) Abstract No. E72, 1984.
25. Preheim LC, Horowitz EA, Safranek TJ, Pugsley MP, Sanders CC, Bittner MJ. Randomized,
double-blind comparison of ceftazidime and moxalactam in complicated urinary tract infections. 24th Interscience Conference on Antimicrobial Agents and Chemotherapy. (Washington, DC) Abstract No 712, October, 1984.
26. Mellencamp MA, Preheim LC. Bactericidal and bacteriostatic activity of cirrhotic rat serum for
Escherichia coli. 85th Annual Meeting American Society for Microbiology, (Las Vegas, NV) Abstract No B179, March, 1985.
27. Preheim LC, Stumpf CA, Bittner M.J. Infection control knowledge among hospital personnel. 85th
Annual Meeting American Society for Microbiology, (Las Vegas, NV) Abstract No L33, March, 1985.
18
PUBLICATIONS: Abstracts (continued) 28. Preheim LC, Stumpf CA, Bittner MJ. Handwashing attitudes and practices among hospital personnel.
85th Annual Meeting American Society for Microbiology, (Las Vegas, NV) Abstract No L59, March, 1985.
29. Preheim LC, Rimland D, Bittner MJ. Prevalence of methicillin-resistant Staphylococcus aureus in V.A.
Medical Centers. 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. (Minneapolis, MN) Abstract No 1033, October, 1985.
30. Horowitz EA, Safranek TJ, Bittner MJ, Preheim LC. Trends in mycobacterial infections in a midwestern
hospital. 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. (Minneapolis, MN) Abstract No. 1036, October, 1985.
31. Mellencamp MA, Preheim LC. A model of pneumococcal pneumonia in cirrhotic rats. 86th Annual
Meeting American Society for Microbiology, (Washington, D.C.) Abstract No B36, 1986. 32. Preheim LC, Cuevas TA, Roccaforte JS, Mellencamp MA, Bittner MJ. Antacid interference with
ciprofloxacin for complicated urinary tract infections in elderly patients. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. (New Orleans, LA) Abstract No 665, September, 1986.
33. Mellencamp MA, Preheim LC. Effect of cirrhosis on bacteremia and capsular antigenemia during
experimental pneumococcal pneumonia. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. (New Orleans, LA) Abstract No 1012, September, 1986.
34. Bittner MJ, Roccaforte JS, Stumpf CA, Preheim LC. Efficacy of trimethoprim/ sulfamethoxazole,
rifampin, and bacitracin ointment in eradication of colonization with methicillin-resistant Staphylococcus aureus. 87th Annual Meeting American Society for Microbiology. (Atlanta, GA) Abstract No. A40, March, 1987.
35. Preheim LC, Cuevas TA, Roccaforte JS, Allais JM, Mellencamp MA, Bittner MJ. Randomized, double
blind comparison of ciprofloxacin and trimethoprim/sulfamethoxazole in complicated urinary tract infections. 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. (New York, NY) Abstract No 293, October, 1987.
36. Mellencamp MA, Preheim LC. Effects of cirrhosis on development of pneumococcal capsular
antibodies. Clin Res 35:858A, 1987. Midwest Section American Federation of Clinical Research, (Chicago, IL) November 1987.
37. Sookpranee T, Sookpranee M, Mellencamp MA, Preheim LC. In vitro susceptibility of 199
Pseudomonas pseudomallei strains to conventional and new antibiotics. 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. (Los Angeles, CA) Abstract No 544, October, 1988.
38. Davis CC, Preheim LC, Mellencamp MA. Effects of ethanol (EtOH) on bacteremia, capsular
antigenemia, and mortality of experimental pneumococcal pneumonia. 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. (Los Angeles, CA) Abstract No 1403, October, 1988.
39. Lister PD, Preheim LC, Mellencamp MA. Effects of cirrhosis (C) on transferrin (Tr)-mediated serum
inhibition of Escherichia coli. 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. (Los Angeles, CA) Abstract No 629, October, 1988.
40. Davis CC, Mellencamp MA, Preheim LC, West WW. Effects of ethanol on pulmonary clearance of
Streptococcus pneumoniae. Clin Res 37:908A, 1989. Midwest Section American Federation of Clinical Research, (Chicago, IL) November, 1989.
19
PUBLICATIONS: Abstracts (continued) 41. Cookson BD, Preheim LC, Pitcher DG, Stappleton P, Owen RJ. Biotin-labelled ribosomal typing of
methicillin-resistant Staphylococcus aureus (MRSA). Abstracts of 2nd International meeting of Bacterial Epidemiological Markers (Rhodes, Greece) p 148, May 1990.
42. Auten G, Sookpranee M, Preheim L, Bittner M, Sookpranee T, Vibhagool A. Ofloxacin serum levels
after intravenous and oral therapy for skin infections in hospitalized adults. 90th Annual Meeting Amer Soc for Micro, (Anaheim, CA) Abstract No A88, April, 1990.
43. Preheim LC, Auten GM, Sookpranee M, Bittner, MJ, Sookpranee T, Vibhagool A. Safety and efficacy
of ofloxacin therapy for skin and soft tissue infections in hospitalized adults. 3rd International Symposium on New Quinolones, (Vancouver, BC) Abstract No 411, July, 1990.
44. Lentino JR, Preheim LC, Mellencamp MA, Dworzack DL. Oral ciprofloxacin versus parenteral
ceftriaxone in the therapy of osteomyelitis due to Staphylococcus aureus and other pathogens. 3rd International Symposium on New Quinolones, (Vancouver, BC) Abstract No 397, July, 1990.
45. Lister PD, Preheim LC, Gentry MJ. Ethanol (EtOH) impairs neutrophil (PMNL) chemotaxis but not
adherence or recruitment to lungs in rats with experimental pneumococcal (Pnc) pneumonia. 92nd Annual Meeting Amer Soc for Micro. (New Orleans, LA) Abstract No 579, May, 1992.
46. Grubb W, Preheim L, Reith S, Cookson B. Resistotyping of MRSA. 7th International Symposium on
Staphylococci and Staphylococcal Infections, (Stockholm, Sweden) Abstract No 174, June, 1992. 47. Lister PD, Gentry MJ, Preheim LC. Ethanol ingestion impairs bactericidal activity of rat neutrophils
against Streptococcus pneumoniae despite normal killing of Staphylococcus epidermidis. 32nd Interscience Conference of Antimicrobial Agents and Chemotherapy, (Anaheim, CA) Abstract No 1560, October, 1992.
48. Preheim LC, Childs SJ, Rajfer J, Bittner MJ. Randomized, Double-Blind Comparison of Cefepime (CP)
vs Ceftazidime (CZ) in Urinary Tract Infections. 93rd Annual Meeting Amer Soc for Micro (Atlanta, GA) Abstract No A51, May, 1993
49. Lister PD, Gentry MJ, Preheim LC. Granulocyte colony-stimulating factor (G-CSF) protects control, but
not ethanol-fed rats from fatal type 3 pneumococcal pneumonia. 93rd Annual Meeting Amer Soc for Micro. (Atlanta, GA) Abstract No. E27, May, 1993.
50. Gentry MJ, Snitily MU, Preheim LC. Pulmonary Phagocytosis of Type 3 Streptococcus pneumoniae
Measured in vivo in a Rat Model of CCl4-Induced Cirrhosis. 93rd Annual Meeting Amer Soc for Micro (Atlanta, GA) Abstract No E8, May, 1993.
51. Bittner MJ, Horowitz EA, Safranek TJ, Preheim LC. Twenty-year trends in mycobacterial infections and
drug susceptibility at a mid-west hospital. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, (New Orleans, LA) Abstract No 611, October, 1993.
52. Horowitz EA, Bittner MJ, Safranek TJ, Preheim LC. Emergence of Mycobacterium kansasii as the
leading mycobacterial pathogen over a 20-year period at a mid-west hospital with declining Mycobacterium tuberculosis. Annual Meeting, Infectious Diseases Society of America, (New Orleans, LA) Clin Infect Dis 1993;17:575 (Abstract No. 265).
53. Jareo P, Preheim LC, Gentry MJ. The Effect of Ethanol Ingestion on Killing of Streptococcus
pneumoniae, Staphylococcus aureus, and Staphylococcus epidermidis by Rat Neutrophils (PMNL). 94th General Meeting Amer Soc for Micro. (Las Vegas, NV) Abstract No B254, May, 1994.
20
PUBLICATIONS: Abstracts (continued) 54. Hanson MN, Erice A, Talarico CL, Preheim LC, Biron KK, Stanat SC, Balfour HH Jr. Characterization
of a novel mutation in the UL97 gene of a clinical cytomegalovirus (CMV) strain conferring resistance to gancyclovir (GCV). 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, (Orlando, FL) Abstract No H25, October, 1994.
55. Preheim LC, Snitily MU Gentry MJ. In vivo assays of phagocytosis and killing of pneumococci by LPS-
activated pulmonary phagocytes in a rat model of CC4-induced liver cirrhosis. Annual Meeting, Infectious Diseases Society of America, (Orlando, FL) Clin. Infect. Dis. 1994;19:614 (Abstract No 301).
56. Jareo P, Preheim LC, Gentry MJ. Effect of rat ingestion on rat neutrophil (PMNL) phagocytic activity
and susceptibility to metabolic suppression by Streptococcus pneumoniae, Annual Meeting, Research Society on Alcoholism, (Steamboat Springs, CO) Abstract No 114, June 1995.
57. Henrikson J, Preheim L, Gentry MJ. Effect of ethanol on antibody response and susceptibility to Type
3 Streptococcus pneumoniae infection. 96th General Meeting American Society for Microbiology (New Orleans) Abstract No B271, April, 1996.
58. Jareo PW, Preheim LC, Gentry MJ. Ethanol ingestion impairs neutrophil (PMNL) bactericidal
mechanisms against Streptococcus pneumoniae. Annual meeting, Research Society on Alcoholism, (Washington, DC) Abstract No 669, June, 1996.
59. Gentry MJ, Lyman KN, Thiele GM, Preheim LC. Alteration of iron withholding capacity by ingestion of
the Lieber - DeCarli liquid control diet. Annual meeting, Research Society on Alcoholism, (Washington, DC) Abstract No 667, June, 1996.
60. McCashland TM, Gentry MJ, Preheim LC. Pneumococcal vaccine response is reduced by cirrhosis
and liver transplantation. Annual Meeting, American Assoc. For the Study of Liver Diseases (Chicago, IL) Abstract No 716, November, 1996. Hepatology 1996; 24 (suppl.):305A.
Henriksen JL, Preheim LC, Gentry MJ. Antibody production and protection by vaccination of ethanol-fed rats with pneumococcal capsular polysaccharide (PnCP). Annual Meeting, Research Society on Alcoholism (San Francisco, CA). Abstract No 243, July, 1997.
61. Preheim LC. Career opportunities for Infectious Diseases subspecialty physicians. 35th Annual
meeting. Infectious Diseases Society of America, (San Francisco, CA). Clin. Infect. Dis. 1997; 25:483. (Abstract No. 693).
62. Gorby GL, Gentry MJ, Preheim LC. Virtual reality microscopy enables visualization of bacteria/host
relationships in models of infection. 35th Annual meeting. Infectious Diseases Society of America, (San Francisco, CA). Clin. Infect. Dis. 1997; 25:372. (Abstract No. 93).
63. Preheim LC, Yue M, Snitily MU, Olsen KM, Gentry MJ. Comparison of azithromycin, trovafloxacin and ceftriaxone for pneumococcal pneumonia in ethanol-fed rats. 4th International Conference on the Macrolides, Azalides, Streptogramins & Ketolides (Barcelona, Spain). Abstract No. 10.03, January, 1998. 64. Alcantara R, Preheim L, Gentry M. Role of pneumolysin and its complement-activating activity during pneumococcal bacteremia in the cirrhotic host. 98th Annual Meeting Amer Soc for Micro. (Atlanta, GA) Abstract No. B297, May, 1998. 65. Gentry MJ, Preheim LC, McDonough KH, Potter BS. Use of rat models to mimic iron homeostasis in
alcohol abuse. Annual Meeting, Research Society on Alcoholism (Hilton Head, SC). Abstract No. 642, June, 1998.
21
PUBLICATIONS: Abstracts (continued) 66. Preheim LC, Gentry MJ, Yue M, Snitily MU, Olsen KM. Efficacy and pharmacokinetics of azithromycin,
trovafloxacin, and ceftriaxone in cirrhotic rats with pneumococcal pneumonia. International Symposium on Pneumococci and Pneumococcal Disease (Elsinore, Denmark). Abstract No. P30, June, 1998.
67. Preheim LC, Gentry MS, Snitily MU, Preheim HA, McCashland TM. Isotypic response to pneumococcal
vaccine in liver transplant patients. International Symposium on Pneumococci and Pneumococcal Disease (Elsinore, Denmark). Abstract No. P68, June, 1998.
68. Ellbogen M, Olsen K, Yue M, Snitily M, Gentry M, Preheim L. Efficacy and pharmacokenetics of
ciprofloxacin (CIP), liposomal ciprofloxacin (L-CIP), and ceftriaxone (CFT) in rats with pneumococcal (PNC) pneumonia. 36th Annual Meeting of the Infectious Diseases Society of America (Denver, CO). Abstract No. 259, November, 1998.
69. Alcantara RB, Preheim LC, Gentry MJ. Effects of pneumolysin’s complement-activating activity on serum
complement levels during pneumococcal bacteremia of cirrhotic and control rats. 99th Annual Meeting, Amer Soc for Micro (Chicago, IL) Abstract No. B/D256, June, 1999.
70. Preheim LC, Olsen KM, Gentry-Nielsen MJ. Efficacy and pharmacokinetics of levofloxacin, trovafloxacin,
and moxifloxacin in ethanol-fed rats with experimental pneumococcal pneumonia. 37th Annual Meeting, Infectious Diseases Society of America (Philadelphia, PA) Abstract No. 73, November 1999.
71. Olsen KM, Preheim LC, Gentry-Nielsen MJ. The pharmacodynamic activity and efficacy of linezolid in a
rat model of Pneumococcal pneumonia. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto, Ontario, Canada). Abstract No. 2251, September, 2000.
72. Gentry-Nielsen MJ, Gerriets JE, Agrawal DK, Preheim LC. Upregulation of platelet activating factor
receptors facilitates pneumococcal pneumonia in cirrhotic hosts. 42nd Meeting of Infectious Diseases Society of America (Boston, MA). Abstract No. 1087. October, 2004.
73. Pitz AM, Branch-Woods A, Preheim LC, Alnouti Y, Olsen KM. Comparison of telavancin, ceftriaxone, and vancomycin efficacy in a rat model of pneumococcal pneumonia. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, (Boston, MA) Abstract No. 1503, September, 2010.
74. Olsen KM, Pitz AM, Massoomi F, Branch-Woods A, Crotty M, Preheim L. A novel method for comparison of microbiologic growth in intravascular devices: Evaluation of three devices. 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, (Chicago, IL) Abstract No. K1434, September, 2011.
75. Destache CJ, Knaak E, Elsasser GN, Cavalieri S, Preheim L. Antibiotic de-escalation for ICU pneumonia:
What is the impact? 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, (Chicago, IL) Abstract No. K1454, September, 2011.
76. Anthone J, Vivekanandan R, Mindru C, Ali K, Ali M, Horowitz E, Bittner M, Gorby G, Destache C, Preheim
L. Impact of an antimicrobial stewardship program (ASP) on antimicrobial usage and incidence of Clostridium difficile infections (CDI) at a teaching hospital. Infectious Diseases Week. (San Francisco, CA) Abstract No. 1016, September, 2013.
77. Foral P, Jamieson E, Bittner M, Gorby G, Horowitz E, Ali K, Neemann K, Vivekanandan R, Mindru C, Ali M, Hrdy M, Horne J, Dobronski L, Preheim L. Provider acceptance and impact of a consultative, non-coercive antimicrobial stewardship program at a Veterans Affairs medical center. American College of Clinical Pharmacy Annual Meeting (Austin, TX), Abstract No. 268. October, 2014.
22
78. Foral P, Anthone J, Horne J, Dobronski L, Syed J, Destache C, Vivekanandan R, Preheim L, Gorby G, Bittner M. Incorporating Interprofessional Practice Education and Motivational Interviewing Techniques in Antimicrobial Stewardship Programs at Two Academic Medical Centers. IDWeek 2015, San Diego, California, October 8, 2015. P 428
23
POSTGRADUATE AND CONTINUING EDUCATION LECTURES
1. Guest Lecturer, Medical Conference, St. Joseph Hospital, Chippewa Falls, WI. 1978. 2. Guest Lecturer, American College of Physicians Nebraska Regional Review Course, Omaha, NE.
1978. 3. Guest Lecturer, Methodist Hospital, Postgraduate Course, Omaha, NE. 1978. 4. Guest Lecturer, University of Nebraska Medical Center Grand Rounds, Omaha, NE. 1978. 5. Guest Lecturer, Hospital Staff Meeting, Fond du Lac Hospital, Fond du Lac, WI. 1979. 6. Guest Lecturer, Annual Meeting of the Missouri Valley Branch of the American Society for
Microbiology, Omaha, NE. 1979. 7. Guest Lecturer, Medical Science Seminar, Olney, IL. 1979. 8. Faculty Lecturer, Creighton University/Arcan Associates Infectious Diseases Seminar, Dromoland,
Ireland. 1979. 9. Guest Lecturer, Infection Control Conference, Clarkson Hospital, Omaha, NE. 1980. 10. Faculty Lecturer, Creighton University/Arcan Associates Infectious Diseases Seminar, Juneau, AK.
1980. 11. Chairman, Omaha Midwest Clinical Society Infectious Diseases Seminar, Omaha, NE. 1980. 12. Guest Lecturer, Platte County Medical Society, Columbus, NE. 1980. 13. Guest Lecturer, Symposium on Prevention of Pneumonia, St. Louis University, St. Louis, MO. 1981. 14. Guest Lecturer, Medical Grand Rounds, St. Mary's Health Center, St. Louis, MO. 1981. 15. Guest Lecturer, The DuPage County Medical Society, Lombard, IL. 1981. 16. Faculty Lecturer, Creighton University Family Medicine Update, Lake Okoboji, IA. 1981. 17. Guest Lecturer, McPherson Memorial Hospital Grand Rounds, McPherson, KS. 1981. 18. Guest Lecturer, Medical Grand Rounds, Bethel Deaconess Hospital, Newton, KS. 1981. 19. Faculty Lecturer, Creighton University/Arcan Associates Infectious Diseases Seminar, Cancun,
Mexico. 1982. 20. Symposium Co-Chairman, "Advances in Management of Serious Infections," Creighton University,
Omaha, NE. 1982. 21. Guest Lecturer, Omaha Mid-West Clinical Society, Omaha, NE. 1982. 22. Guest Lecturer, Kansas City Southwest Clinical Society, Kansas City, KS. 1982. 23. Guest Lecturer, Brookings Memorial Hospital, Medical Grand Rounds, Brooking, SD. 1982. 24. Faculty Lecturer, Creighton University/Arcan Associates Infectious Diseases Seminar, Kona, HI.
1982. 25. Guest Lecturer, Carroll County Medical Society Meeting, St. Anthony Hospital, Carroll, IA. 1983. 26. Guest Lecturer, Medical Grand Rounds, VA Medical Center, Des Moines, IA. 1983. 27. Symposium Director, "Symposium on the Prevention of Infectious Diseases," Creighton University,
Omaha, NE. 1983. 28. Guest Lecturer, Dodge County Memorial Hospital, Grand Rounds, Fremont, NE. 1983. 29. Faculty Lecturer, Department of Surgery Grand Rounds, St. Joseph Hospital, Omaha, NE. 1983. 30. Guest Lecturer, Omaha Midwest Clinical Society, Omaha, NE. 1983. 31. Guest Lecturer, St. Joseph Medical Center Medical Staff Meeting, Ponca City, OK. 1983. 32. Faculty Lecturer, Department of Family Practice Journal Club, St. Joseph Hospital, Omaha, NE. 1984 33. Symposium Director, "Developments in Diagnosis and Therapy of Infectious Diseases," Creighton
University, Omaha, NE. 1984. 34. Guest Lecturer, Medical Grand Rounds, VA Medical Center, Des Moines, IA. 1984. 35. Guest Lecturer, Kennewick General Hospital, Grand Rounds, Kennewick, WA. 1984. 36. Guest Lecturer, Nebraska Infection Control Network 1984 Educational Conferences, Omaha, NE.
1984. 37. Guest Lecturer, Omaha-Midwest Clinical Society Meeting, Omaha, NE. 1984. 38. Guest Lecturer, Medical Grand Rounds, Northwest Hospital, Tucson, AZ. 1984. 39. Guest Lecturer, Symposia on Advances in Cephalosporin Therapy, Phoenix, AZ; Miami, FL;
Philadelphia, PA; Washington, D.C.; NY, NY; Detroit, MI; Raleigh, NC; Atlanta, GA; St. Louis, MO; Pittsburgh, PA. 1985.
40. Faculty Lecturer, Creighton University/Arcan Associates Infectious Diseases Seminar, Ixtapa, Mexico. 1985.
24
41. Symposium Director, "Update on Infectious Diseases," Creighton, University, Omaha, NE. 1985.
42. Faculty Lecturer, Department of Medicine Conference, "Meningitis," Saint Joseph Hospital, Omaha, NE. 1985.
43. Faculty Lecturer, Department of Medicine Conference, "Atypical Mycobacterial Infections," Veterans Administration Medical Center, Omaha, NE. 1986.
44. Symposium Director, Infectious Diseases Symposium, "Update On AIDS," Creighton University, Omaha, NE. 1986.
45. Faculty Lecturer, Antibiotic Update, "AIDS: Approach to the Patient and the Health Care Worker," Family Practice Update, Lake Okoboji, IA. 1986.
46. Guest Lecturer, Medical Staff Meeting, "Beta lactam Antibiotic Update," Freeman Community Hospital, Freeman, SD. 1986.
47. Faculty Lecturer, Medical Grand Rounds, "Fungal Infections," Department of Medicine, Creighton University, Omaha, NE. 1986.
48. Guest Lecturer, Omaha-Midwest Clinical Society Meeting, "Antiviral Therapy," Omaha, NE. 1986. 49. Co-author of two papers presented at Ciprofloxacin Symposium, Fort Lauderdale, FL. 1986. 50. Faculty Lecturer, Creighton University/Arcan Associates Infectious Diseases Seminar, Puerto
Vallarta, Mexico. 1987. 51. Symposium Director, "7th Annual Infectious Diseases Symposium," Creighton University School of
Medicine, Omaha, NE. April 15, 1987. 52. Guest Lecturer, Saint Francis Annual Drug Education Conference, "Quinolone Antibiotics," Wichita,
KS. 1987. 53. Faculty Lecturer, Family Practice Update, "AIDS Update," "Sexually Transmitted Diseases,"
"Outpatient Infectious Diseases," Lake Okoboji, IA. 1987. 54. Faculty Lecturer, Medical Grand Rounds, "Rational Selection of Antibiotics," Department of
Medicine, Creighton University, Omaha, NE. 1987. 55. Faculty Lecturer, Creighton University/Arcan Associates Infectious Diseases Seminar, "New
Antibiotics," "Rational Selection of Antibiotics," "Outpatient Infectious Diseases," "New Infections," "AIDS," "Deep Fungal Infections," Grand Cayman, B.W.I. 1987.
56. Faculty Lecturer, Creighton University symposium: "Understanding AIDS," Omaha, NE. 1987. 57. Faculty Lecturer, Medical Conference, "Fever of Unknown Origin," Creighton University, Omaha,
NE. 1987. 58. Guest Lecturer, Pulmonary Forum, "Mycobacterial Infections: New Problems, New Solutions,"
Tucson, AZ. 1988. 59. Guest Lecturer, Medical Grand Rounds, "Treatment of Elderly Patients with Complicated Urinary
Tract Infections," VA Medical Center, Des Moines, IA. 1988. 60. Guest Lecturer, Association for Practitioners in Infection Control, "Surgical Wound Infections,"
Council Bluffs, IA. 1988. 61. Symposium Director, "8th Annual Infectious Diseases Symposium," Creighton University School of
Medicine, Omaha, NE. 1988. 62. Guest Lecturer, Research Conference, "Ecologic Trends and Mechanisms of Microbial Resistance
to Antibiotics," VA Medical Center, Omaha, NE. 1988. 63. Faculty Lecturer, Medical Grand Rounds, "Rational Approach to Empiric Antibiotic Therapy,"
Department of Medicine, Creighton University, Omaha, NE. 1988. 64. Guest Lecturer, Lincoln Family Medicine Program, "Complicated Urinary Tract Infections in the
Elderly," Lincoln, NE. 1988. 65. Guest Lecturer, University of Nebraska Medical Residents' Conference, "Rational Approach to
Empiric Antibiotic Therapy," Veterans Administration Medical Center, Omaha, NE. 1988. 66. Guest Lecturer, Medical Grand Rounds, "Quinolone Antibiotics: Development, Current Indications,
Future Use," Medical College of Wisconsin, Milwaukee, WI. 1988. 67. Guest Lecturer, Saint Francis Hospital Staff Meeting, "Antibiotic Update," Saint Francis Hospital,
Milwaukee, WI. 1988.
25
POSTGRADUATE AND CONTINUING EDUCATION LECTURES (continued)
68. Guest Lecturer, Saint Joseph Hospital Staff Meeting, "Mycobacterial Infections: New Problems, New Solutions," Saint Joseph Hospital, Milwaukee, WI. 1988.
69. Guest Lecturer, University of Chicago/Michael Reese Hospital Infectious Diseases Conference, "Mycobacterial Infections: New Problems, New Solutions," Chicago, IL. 1989.
70. Guest Lecturer, Chicago Area Infectious Diseases Society, "Mycobacterial Infections: New Problems, New Solutions," Chicago, IL. 1989.
71. Guest Lecturer, Hertzler Research Foundation Seminar, "Antibiotics for the Ambulatory Patient," Halstead, KS. 1989.
72. Guest Lecturer, Biologic Sciences Seminar, "Mechanisms of Microbial Resistance to Antibiotics," Bethel College, N. Newton, KS. 1989.
73. Guest Lecturer, Carl T. Curtis Health Center Geriatric Program, "New Developments in Infection Control," Macy, NE. 1989.
74. Guest Lecturer, Medical Grand Rounds, "Methicillin-resistant Staphylococcus aureus: Evolution of a Nosocomial Pathogen," Hines Veterans Administration Medical Center, Chicago, IL. 1989.
75. Faculty Lecturer, Microbiology Research Seminar, "Atypical mycobacteria: New Challenges and New Solutions," St. Thomas's Hospital, United Medical and Dental Schools, London, England. 1989.
76. Guest Lecturer, Pulmonary Forum, "Mycobacterial Infections: New Problems, New Solutions," Newport Beach, CA, November 4-5, 1989.
77. Faculty Lecturer, Faculty Seminar, Department of Medical Microbiology, "Genetic Studies Related to MRSA," Creighton University School of Medicine, Omaha, NE, November 13, 1989.
78. Faculty Lecturer, Research Conference, Department of Medicine, "Pathogenesis of Pneumococcal Infections in Cirrhosis," Creighton University School of Medicine, Omaha, NE, February 1, 1990.
79. Faculty Lecturer, Creighton University/Arcan Associates Infectious Diseases Seminar, "New Antibiotics," Empiric Antibiotic Therapy," Mycobacterial Infections," "Sexually Transmissible Diseases," "Nosocomial Infections," Cancun, Mexico, March 8-17, 1990.
80. Symposium Director, "10th Annual Infectious Diseases Symposium," Creighton University School of Medicine, Omaha, NE, April 6, 1990.
81. Faculty Lecturer, 10th Annual Infectious Diseases Symposium, "Mycobacterial Infections: An Atypical Success Story," Creighton University, Omaha, NE, April 6, 1990.
82. Faculty Lecturer, Research Conference, Department of Medicine "Resistotyping and Ribotyping of Methicillin-resistant Staphylococcus aureus," Creighton University, Omaha, NE, April 19, 1990.
83. Guest Lecturer, Medical Grand Rounds, "Mycobacterial Infections: An Atypical Success Story," Wayne State University School of Medicine, Detroit, MI, May 2, 1990.
84. Guest Lecturer, AIDS Update Seminar, "Clinical Features of AIDS", Assistance League of Omaha, Omaha, Nebraska, NE, May 5, 1990.
85. Guest Lecturer, Heartland Conference on Geriatric Health Care, "Infectious diseases in the elderly", Omaha, NE, August 23-25, 1990.
86. Guest Lecturer, Medical Grand Rounds, "Mycobacterial Infections: New Problems, New Solutions," St. Luke’s Hospital, Texas Medical Center, Houston, TX, February 11, 1991.
87. Guest Lecturer, Infectious Diseases Research Conference, "Pathogenesis of pneumococcal infections in a rat model of cirrhosis", St. Luke’s Hospital, Texas Medical Center, Houston, TX, February 11, 1991.
88. Guest Lecturer, Family Practice Grand Rounds, "Infections in the Elderly," Department of Family Practice, Michigan State University, Kalamazoo, MI, February 21, 1991.
89. Guest Lecturer, Family Practice Grand Rounds, "Infections in the Elderly," Department of Family Practice, Creighton University, Omaha, NE, March 19, 1991.
90. Guest Lecturer, Medical Staff Meeting, "MRSA Infections," Burgess Memorial Hospital, Onawa, IA, April 1, 1991.
91. Symposium Director. "11th Annual Infectious Diseases Symposium," Creighton University School of Medicine, Omaha, NE, April 12, 1991.
92. Guest Lecturer, Northeast Nebraska Medical Association Meeting, "Mycobacterial Infections: New Challenges, New Solutions," Norfolk, NE, June 27, 1991.
26
POSTGRADUATE AND CONTINUING EDUCATION LECTURES: (continued)
93. Guest Lecturer, Nebraska Association for Practitioners in Infection Control, "Tuberculosis: A New
Challenge in the 90's," Omaha, NE, December 5, 1991. 94. Guest Lecturer, Medical Staff Conference, "Tuberculosis and Other Mycobacterial Infections," St.
Luke’s Hospital, Cedar Rapids, IA, January 8, 1992. 95. Guest Lecturer, University of Iowa Family Practice Grand Rounds, "Tuberculosis and Other
Mycobacterial Infections," Iowa City, IA, January 8, 1992. 96. Guest Lecturer, Infectious Diseases Conference. "Mycobacterial Infections," University of Texas
Medical Branch, Galveston, TX, February 4, 1992. 97. Guest Lecturer, Geriatric Grand Rounds, "Infections in the Elderly," University of Nebraska Geriatric
Center, Omaha, NE, February 24, 1992. 98. Guest Lecturer, University of Nebraska Medical Center Family Practice Review Course, "New
Infections," Omaha, NE, March 31, 1992. 99. Symposium Director, "12th Annual Infectious Diseases Symposium," Creighton University School of
Medicine and University of Nebraska Medical Center, Omaha, NE, April 10, 1992. 100. Guest Lecturer," Tuberculosis and Other Mycobacterial Infections," Red Lion Inn, Omaha, NE, May
7, 1992. 101. Guest Lecturer, Medical Grand Rounds, "Tuberculosis and Other Mycobacterial Infections," Des
Moines General Hospital, Des Moines, IA, May 27, 1992. 102. Guest Lecturer, Medical Staff Conference, "Tuberculosis and Other Mycobacterial Infections,"
Mercy Hospital, Des Moines, IA, May 27, 1992. 103. Faculty Lecturer, "Mycobacterial Infections: New Challenges and New Solutions," University of
Nebraska Medical Center Grand Rounds, Omaha, NE, June 12, 1992. 104. Guest Lecturer, Medical Staff Conference, "Advances in Oral Antibiotic Therapy," Emmanuel
Hospital, Portland, OR, June 18, 1992. 105. Guest Lecturer, Family Practice Grand Rounds, "Tuberculosis and Other Mycobacterial Infections,"
University of Nebraska Medical Center Omaha, NE, July 15, 1992. 106. Faculty Lecturer, Department of Medicine Grand Rounds, "Advances in Oral Antimicrobial
Therapy," Creighton University, Omaha, NE, August 12, 1992. 107. Guest Lecturer, "Tuberculosis and Other Mycobacterial Infections," Great Plains Regional Medical
Center, North Platte, NE, August 19, 1992. 108. Guest Lecturer, "Tuberculosis and Other Mycobacterial Infections," Webster County Medical
Society, Ft. Dodge, IA, September 8, 1992. 109. Guest Lecturer, “New Infections and Emerging Pathogens,” Bureau in Infection Management
Conference, San Diego, CA, October 3, 1992. 110. Faculty Lecturer, "New Oral Antibiotics," Omaha VAMC Medical Service Conference, Omaha, NE,
October 10, 1992. 111. Guest Lecturer, "Nosocomial Pneumonia," American College of Physicians Nebraska Chapter
Annual Meeting, Ashland, NE, October 16, 1992. 112. Guest Lecturer, "Tuberculosis and Other Mycobacterial Infections," UNMC College of Pharmacy
Practice and Research Conference, Omaha, NE, November 21, 1992. 113. Guest Lecturer, "Advances in Oral Antibiotic Therapy," Anti-Infective Visiting Faculty Program,
Arlington Heights, IL, December 2, 1992. 114. Guest Lecturer, "New Infections", University of Nebraska Family Practice Review Course, Omaha,
NE, March 30 and May 4, 1993. 115. Symposium Director, "13th Annual Infectious Diseases Symposium," Creighton University School of
Medicine and University of Nebraska Medical Center, Omaha, NE, April 30, 1993. 116. Faculty Lecturer, Omaha VAMC Medical Service Conference, "New Infections", Omaha, NE,
September 11, 1993. 117. Guest Lecturer, Burgess Memorial Hospital, "MRSA", Onawa, IA, September 15, 1993. 118. Guest Lecturer, Omaha Midwest Clinical Society Meeting, "New Macrolides", Omaha, NE, October
6, 1993. 119. Guest Lecturer, "New Infections", University of Nebraska Family Practice Review Course, Omaha,
27
NE, March 18 and April 22, 1994. 120. Symposium Director, "14th Annual Infectious Diseases Symposium," Creighton University School of
Medicine and University of Nebraska Medical Center, Omaha, NE, April 15, 1994. 121. Faculty Lecturer, “New Infections,” University of Nebraska Department of Internal Medicine
Conference, Omaha, NE, April 21, 1994. 122. Visiting Professor, AIDS Awareness Day and Convocation. Graceland College, Lamoni, IA, April
27, 1994. 123. Guest Lecturer, “Tuberculosis,” South Dakota Society for Respiratory Care, Sioux Falls, SD, April
28, 1994. 124. Guest Lecturer, “Tuberculosis in the 1990's,” Medical Staff Meeting, Midlands Community Hospital,
Papillion, NE, June 6, 1994. 125. Guest Lecturer, "New and Re-emerging Infections", Topics in Primary Care for Physicians
Assistants, Omaha, NE, September 16, 1994. 126. Faculty Lecturer, "Adult Immunizations", 7th Annual Internal Medicine Update, Lincoln, NE,
September 17, 1994. 127. Guest Lecturer, "The Pneumococcus: New Threats from the Old Man’s Friend", Kansas City
Infectious Diseases Society, Kansas City, MO, November 8, 1994. 128. Guest Lecturer and Visiting Professor, University of Kansas Medical Center, "Mycobacterial
Infections: New Challenges and New Solutions", Kansas City, MO, November 9, 1994. 129. Faculty Lecturer, Department of Medicine Grand Rounds, "The Pneumococcus: New Threats from
the Old Man’s Friend", University of Nebraska Medical Center, Omaha, NE, December 9, 1994. 130. Faculty Lecturer, Department of Medicine Grand Rounds, "The Pneumococcus: New Threats from
the Old Man’s Friend", Creighton University School of Medicine, Omaha, NE, December 21, 1994. 131. Faculty Lecturer, "Liver cirrhosis and host defense against pneumococcal infections", Department of
Medicine Research Conference, Creighton University, Omaha, NE, January 19, 1995. 132. Guest Lecturer, "Streptococcus pneumoniae: New Threats from the Old Man’s Friend", Group
Health Medical Education Conference on Infectious Diseases, Minneapolis, MN, March 11, 1995. 133. Guest Lecturer, "Exploring the Critical Issues in Infectious Diseases", University of Iowa Seminar,
Santa Fe, NM, March 17-18, 1995. 134. Symposium Director, "15th Annual Infectious Diseases Symposium", Creighton University School of
Medicine and University of Nebraska Medical Center, April 21, 1995. 135. Guest Lecturer, "New Infections" and "Tuberculosis", University of Nebraska Family Practice
Review Course, March 31 and April 28, 1995. 136. Guest Lecturer, “Infectious Disease Emergencies,” Medical Grand Rounds, Dwight D. Eisenhower
V.A. Medical Center, Leavenworth, KS, July 19, 1995. 137. Faculty Lecturer, “Infectious Disease Emergencies,” Department of Medicine Conference,
Creighton University, Omaha, NE, August 21, 1995. 138. Faculty Lecturer, “Infectious Disease Emergencies,” Department of Medicine Conference,
University of Nebraska Medical Center, August 24, 1995. 139. Visiting Professor, Loyolla University Medical Center, including Medical Grand Rounds Lecture
“Pneumococcal Infections: New Threats from The Old Man’s Friend,” Maywood, IL, Oct. 17, 1995. 140. Guest Lecturer, “Skin and Soft-tissue Infections,” Dakota Heartland Health System, Fargo, ND, Nov
16, 1995. 141. Faculty Lecturer, “Pathogenesis of Pneumococcal Infections in Cirrhosis,” Dept. of Medicine
Research Conference, Creighton University, Omaha, NE, January 18, 1996. 142. Program Director, “2nd Annual Infectious Diseases Specialist Interactive Conference,” Nordic
Empress, The Bahamas, April 5-8, 1996. 143. Symposium Director, "16th Annual Infectious Diseases Symposium," Creighton University School
of Medicine and University of Nebraska Medical Center, April 26, 1996. 144. Faculty Lecturer, “Antimicrobial Resistance in Long Term Geriatric Care,” “Mycobacterial Infections:
New Threats from Old Diseases, “1996 Primary Care Update. Okaboji, IA, May 24, 1996. 145. Guest Lecturer, “Antimicrobial Resistance in Gram-Positive Pathogens,” Medical Staff Meeting,
Ehrling Berquist Hospital, Bellevue, NE, May 28, 1996. 146. Faculty Lecturer, “Vaccines and Travel Medicine,” Conference on Diagnostic Dilemmas in Women’s
Health Care, Omaha, NE, June 8, 1996.
28
147. Faculty Lecturer, “TB and Other Mycobacterial Infections in HIV Disease,” Laboratory of Viral Pathogenesis Internship Program, University of Nebraska Medical Center, June 10, 1996.
148. Guest Lecturer, “Employment Opportunities for Infectious Diseases Fellows,” Infectious Diseases Society of America Regional Task Force Conference, Chicago, IL, July 12-14, 1996.
149. Faculty Lecturer, “Pneumococcal Infections: New Threats from the Old Man’s Friend,” Department of Medicine Conference, University of Nebraska Medical Center, October 1, 1996.
150. Guest Lecturer, “Infectious Diseases Emergencies” and “New pathogens and Re-emerging Infectious Diseases,” Second Annual Update on Infectious Diseases, St. Francis Medical Center, Topeka, KS, October 3, 1996.
151. Guest Lecturer, “Emerging Resistance Among Problem Pathogens,” Grand Rounds, Mary Lanning Memorial Hospital, Hastings, NE, November 2, 1996.
152. Faculty Lecturer, “New and Re-emerging Infectious Diseases,” Department of Medicine Grand Rounds, Creighton University, Omaha, NE, November 20, 1996.
153. Guest Lecturer, “Emerging Resistance Among Problem Pathogens,” Hall County Medical Center, Grand Island, NE, February 25, 1997.
154. Guest Lecturer, “Emerging Resistance Among Problem Pathogens,“ Medical Staff Conference, VA Medical Center, Lincoln, NE, April 16, 1997.
155. Co-Chair, Session on Manpower Issues. Presentation: “Job Opportunities for Infectious Diseases Physicians.” National Meeting of Infectious Diseases Division Directors, April 18-20, 1997, Dallas, Texas.
156. Symposium Director, “17th Annual Infectious Diseases Symposium,” University of Nebraska Medical Center and Creighton University School of Medicine, April 24, 1997.
157. Faculty Lecturer, “Infectious Diseases Emergencies,” Department of Medicine Conference, Creighton University, Omaha, NE, August 11, 1997.
158. Guest Lecturer, “New and Re-emerging Infectious Diseases,” Grand Rounds, Marion County Medical Center, Sioux City, IA, September 12, 1997.
159. Guest Lecturer, “Emerging Resistance Among Problem Pathogens,” Kansas City Southwest Clinical Society 75th Annual Conference, Kansas City, KS, October 23, 1997.
160. Visiting Professor, Harold D. Rose Memorial Lectureship, “Pneumococcal Infections: New Threats from the Old Man’s Friend,” Medical College of Wisconsin Medical Center Grand Rounds, Milwaukee, WI, October 30-31, 1997.
161. Faculty Lecturer, “Mycobacterial Infections in Nebraska,” Department of Medicine Grand Rounds, University of Nebraska Medical Center, Omaha, NE, November 5, 1997.
162. Faculty Lecturer, “New Antimicrobials in a Rat Model of Pneumococcal Pneumonia.” Department of Medicine Research Conference, Creighton University, Omaha, NE, February 19, 1998.
163. Faculty Lecturer, “New Antimicrobials in a Rat Model of Pneumococcal Pneumonia.” Research Service Conference, VA Medical Center, Omaha, NE, March 6, 1998.
164. Guest Lecturer, “The Pneumonoccus: New Threats from the Old Man’s Friend” and “Update on Quinolone Antibiotics.” Medicine in the Rockies Conference, Colorado Springs, CO, April 4, 1998.
165. Faculty Lecturer, “Update on Quinolone Antibiotics.” Department of Medicine Conference, University of Nebraska Medical Center, Omaha, NE, April 7, 1998.
166. Director, 18th Annual Infectious Diseases Symposium, Creighton University School of Medicine and University of Nebraska Medical Center, Omaha, NE, April 24, 1998.
167. Faculty Lecturer, “Group B Streptococcal Infections and Epidural Abscess” Department of Medicine, Creighton University, Omaha, NE, June 8, 1998.
168. Faculty Lecturer, “Infectious Diseases Emergencies,” Department of Medicine Conference, Creighton University, Omaha, NE, August 10, 1998.
169. Faculty Lecturer, “Update on Bacterial Meningitis,” Grand Rounds, Department of Neurology, Creighton University, Omaha, NE, October 2, 1998.
170. Metro Omaha Medical Society Health Topics Program. “Antibiotic Resistance.” January 20, 1999. Aired on Cox Cable channel 4, Douglas County Cable Vision channel 24, and US West channel 6.
171. Coordinator, “Controversies in Diagnosis and Management of Community-Acquired Pneumonia.” Department of Medicine Grand Rounds, Creighton University, Omaha, NE, March 31, 1999.
172. Director, 19th Annual Infectious Diseases Symposium, Creighton University School of Medicine and University of Nebraska Medical Center, Omaha, NE, April 29, 1999.
29
173. Faculty Lecturer, “Infectious Diseases Emergencies,” Department of Medicine Conference, Creighton University, Omaha, NE, September 8, 1999.
174. Guest Lecturer, “Update on Community-Acquired Pneumonia.” Philippine Medical Association of Greater St. Louis, Inc., St. Louis, MO, September 12, 1999.
175. Guest Lecturer, “Antibiotic Update: Millennial Promise or Microbial Apocalypse.” Department of Obstetrics and Gynecology Grand Rounds. Creighton University School of Medicine, Omaha, NE, December 15, 1999.
176. Guest Lecturer, “Antibiotic Resistance Among Problem Pathogens.” DePaul Medical Center, St. Louis, MO, March 16, 2000.
177. Faculty Lecturer, “Infectious Diseases: Past, Present and Future.” Creighton University Department of Medicine Update Course, Omaha, NE, April 24, 2000.
178. Director, 20th Annual Infectious Diseases Symposium, Creighton University School of Medicine and University of Nebraska Medical Center, Omaha, NE, April 28, 2000.
179. Guest Lecturer, “Common Infectious Diseases, Consults on Surgical Patients” and “Bacterial Resistance: New Challenges and Solutions.” Society of Abdominal Surgeons 41st Clinical Congress, Tampa, FL, May 5, 2000.
180. Guest Lecturer, “Bacterial Resistance – New Problems and New Solutions.” Medicine Department Grand Rounds, VA Medical Center, Des Moines, IA, July 20, 2000.
181. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 26, 2000.
182. Faculty Lecturer, “Bacterial Resistance – New Problems and New Solutions.” Medicine Department Grand Rounds, Creighton University, Omaha, NE, August 23, 2000.
183. Guest Lecturer, “Bacterial Resistance – New Problems and New Solutions.” Clarkson Family Practice Resident’s Conference, Clarkson Family Medicine, Omaha, NE, October 13, 2000.
184. Guest Lecturer, “Community-Acquired Pneumonia.” Infectious Diseases Update, Omaha, NE, November 18, 2000.
185. Faculty Lecturer, “Community-Acquired Pneumonia.” Medicine Department Ambulatory Core Curriculum, Creighton University, Omaha, NE, February 12, 2001.
186. Director, 21st Annual Infectious Diseases Symposium, Creighton University School of Medicine and University of Nebraska Medical Center, Embassy Suites Old Market, Omaha, NE, April 27, 2001.
187. Guest Lecturer, “Infectious Diseases Emergencies.” Good Samaritan Hospital, Kearney, NE, May 11, 2001.
188. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 25, 2001.
189. Faculty Lecturer, “Blood Transfusion – Related Infections: What’s the Beef About?” Department of Medicine Grand Rounds, Creighton University, Omaha, NE, October 3, 2001.
190. Guest Lecturer, “Infectious Diseases: Past, Present and Future.” Medical Grand Rounds, Christ Hospital, Oak Lawn, IL, October 18, 2001.
191. Faculty Lecturer, “CNS Infections: What’s Hot and What’s Not.” Department of Neurology Grand Rounds, Creighton University, Omaha, NE, February 1, 2002.
192. Director, 22nd Annual Infectious Diseases Symposium, Creighton University School of Medicine and University of Nebraska Medical Center, Embassy Suites Old Market, Omaha, NE, May 3, 2002.
193. Faculty Lecturer, “Infectious Diseases Emergencies.” Emergency Medicine Lecture Series, University of Nebraska Medical Center, Omaha, NE, July 10, 2002.
194. Guest Lecturer, “CNS Infections: What’s Hot and What’s Not.” “Mycobacterial Infections: An Atypical Success Story, “Pneumococcal Infections: New Threats From the Old Man’s Friend.” University of Michigan School of Medicine Infectious Diseases Review Course, Mackinac Island, MI, July 12-14, 2002.
195. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 22, 2002.
196. Guest Lecturer, “Infectious Diseases: Past, Present and Future.” Department of Medicine Grand Rounds, Southern Illinois University School of Medicine, Springfield, IL, October 15, 2002.
197. Guest Lecturer, “Pneumococcal Infections: New Threats from the Old Man’s Friend.” Pulmonary/Infectious Diseases Combined Conference, Southern Illinois University School of Medicine, Springfield, IL, October 15, 2002.
30
198. Director, 23rd Annual Infectious Diseases Symposium, Creighton University School of Medicine and University of Nebraska Medical Center, Embassy Suites Old Market, Omaha, NE, April 25, 2003.
199. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 30, 2003.
200. Faculty Lecturer, “New and Re-emerging Infectious Diseases.” Clinical Update in Internal Medicine Course. Creighton University Department of Medicine, Omaha, NE, April 17, 2004.
201. Michael Rytel Memorial Lecture, “Pneumococcal Infections: New Threats from the Old Man’s Friend.” Infectious Diseases Society of Milwaukee. Milwaukee, WI, April 27, 2004.
202. Director, 24th Annual Infectious Diseases Symposium, Creighton University School of Medicine and University of Nebraska Medical Center, Embassy Suites Old Market, Omaha, NE, April 25, 2004.
203. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 29, 2004.
204. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 27, 2005.
205. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 26, 2006.
206. Guest Lecturer, “Infectious Diseases Challenges in the 21st Century.” Medical Grand Rounds, Good Samaritan Medical Center, Kearney, NE. September 29, 2006.
207. Faculty Lecturer, “Infectious Diseases Challenges in the 21st Century.” Department of Medicine Grand Rounds, Creighton University Medical Center, Omaha, NE. October 25, 2006.
208. Guest Lecturer, “Infectious Diseases Emergencies.” VIP CME Symposium on Emergency Medicine. Good Samaritan Medical Center, Kearney, NE. December 8, 2006.
209. Guest Lecturer, “Bacterial Resistance: New Problems and New Solutions.” Medical Grand Rounds. Good Samaritan Medical Center, Kearney, NE. December 8, 2006.
210. Guest Lecturer, “Infectious Diseases Challenges in the 21st Century.” Medical Grand Rounds, University of Delaware Christiana Medical Center, Wilmington, DE. March 29, 2007.
211. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, August 8, 2007.
212. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, August 14, 2008.
213. Guest Lecturer, “The Curse of CA-MRSA: Coming Soon to a Theater Near You.” Infectious Diseases Critical Care Symposium, Marshall University School of Medicine, Huntington, WV, October 13, 2008.
214. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 30, 2009.
215. Guest Lecturer. “Infectious Diseases Challenges in the 21st Century.” Infectious Diseases Update. Washington State Medical Association. Fircrest, WA. November 6, 2009.
216. Guest Lecturer. “Infectious Diseases Challenges in the 21st Century.” Wyoming State Medical Society/ Wyoming ACP Chapter Annual Meeting. Jackson, WY. June 10, 2010.
217. Guest Lecturer. “Antimicrobial Update: Back to the Future?” Wyoming State Medical Society/ Wyoming ACP Chapter Annual Meeting. Jackson, WY. June 12, 2010.
218. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, August 3, 2010.
219. Convocation Lecture. “Infectious Diseases Challenges in the 21st Century.” Bethel College, N. Newton, KS, April 25, 2011.
220. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 27, 2011.
221. Faculty Lecturer, “Antibiotic Stewardship.” Department of Medicine Grand Rounds, Creighton University, Omaha, NE, November 14, 2011.
222. Faculty Lecturer, “Antibiotic Stewardship.” Department of Family Medicine Grand Rounds, Creighton University, Omaha, NE, January 27, 2012.
223. Faculty Lecturer, “Antibiotic Stewardship.” Department of Surgery Grand Rounds, Creighton University, Omaha, NE, February 13, 2012.
224. Faculty Lecturer, “Bacterial Respiratory Infections.” Department of Medicine Noon Conference. Creighton University, Omaha, NE, April 30, 2012.
31
225. Faculty Lecturer, “Infective Endocarditis.” Department of Medicine Noon Conference. Creighton University, Omaha, NE, May 7, 2012.
226. Faculty Lecturer, “Antibiotic Stewardship Update.” Department of Surgery Teaching Conference, Creighton University, Omaha, NE, April 19, 2013.
227. Faculty Lecturer, “Infectious Diseases Emergencies.” Department of Medicine Conference, Creighton University, Omaha, NE, July 10, 2014.
228. Faculty Lecturer, “21st Century Infectious Diseases Challenges.” Department of Medicine Grand Rounds. Creighton University, Omaha, NE, December 10, 2014.
229. Faculty Lecturer, “21st Staphylococcal Infections.” Department of Medicine Grand Rounds. Creighton University, Omaha, NE, January 20, 2015.
230. Faculty Lecturer, “Skin and Soft Tissue Infections.” Department of Medicine Conference, Creighton University, Omaha, NE, November 11, 2016.
231. Guest Faculty. , “21st Century Infectious Diseases Challenges.” Wyoming Medical Center “Frontiers in Wyoming Medicine Conference,” Jackson Hole, WY February 17-19, 2017.
GRADUATE STUDENTS AND INFECTIOUS DISEASES DIVISION FELLOWS (Subsequent Position): Robert G. Penn, M.D. 1979-1981 (Private practice, Omaha, NE) John B. Warner, M.S. 1980-1983 (Instructor, Purdue University, Lafayette, IN) Mary P. Pugsley, M.D. 1981-1983 (Assistant Professor, Creighton University, Omaha, NE) Edward A. Horowitz, M.D. 1982-1984 (Assistant Professor, Creighton University, Omaha, NE) Martha A. Mellencamp, Ph.D. Post-doctoral 1983-1985 (Assistant Professor, Creighton University, Omaha, NE) Kevin Knutson, M.S. program 1983-1984 (transferred to Iowa State University) Thomas J. Safranek, M.D. 1983-1984 (EIS, Centers for Disease Control, Atlanta, GA) Thomas A. Cuevas, M.D. 1984-1986 (Chief, Infectious Diseases, VAMC, Leavenworth, KS) Jane S. Roccaforte, M.D. 1985-1987 (Private practice, Omaha, NE) Jean M. Allais, M.D. 1986-1988 (Private practice, Laramie, WY) Mondej Sookpranee, M.D. 1987-1989 (Assistant Professor, Khon Kaen University, Thailand) Tassanee Sookpranee, M.D. 1987-1989 (Assistant Professor, Khon Kaen University, Thailand) Catherine C. Davis, Ph.D. 1988-1989 (Vipont, Inc., Fort Collins, CO) Grace M. Auten, M.D. 7/88-12/89 (transferred to Washington Hospital Center, Washington, D.C.) Louis L. Safranek, M.D., Ph.D. 1/90-7/90 (Assistant Professor, Creighton University, Omaha, NE) Asda Vibhagool, M.D. 1989-1991 (Research Fellow with Dr. Jon Mader, U. of Texas, Galveston, TX) Philip D. Lister, Ph.D. 1989-1992 (Post-doctoral with Dr. Christine Sanders, Creighton University, Omaha, NE) Daniel J. Schroeder, M.D. 1990-1992 (Private practice, Des Moines, IA) Daniel J. Boken, M.D. 1991-1993 (Pediatric Infectious Diseases Fellowship, Creighton University, Omaha, NE) Andrea M. Prevan, D.O. 1992-94 (Post-doctoral with Dr. Christine Sanders, Creighton University, Omaha, NE) Jenae D. Limoges, M.D. 1993-95 (Research Fellow with Dr. Howard Gendelman, UNMC, Omaha, NE) Joseph W. Barry, M.D. 1994-96 (Private practice, Kansas City, KS) Jorge R. Reyno, M.D. 1994-96 (Private practice, Rapid City, SD) Terri Smith, M.D., 1995-97 (EIS, Centers for Disease Control, Atlanta, GA) Elizabeth Lien, M.D., 1996-98 (Instructor, University of Nebraska College of Medicine, Omaha, NE) Winai Ratanasuwan, M.D., 1996-98 (Research Fellow with Dr. Howard Gendelman, UNMC, Omaha, NE) Thomas Stalder, M.D., 1997-99 (Private practice, Lincoln, NE) Martin Ellbogen, Jr., M.D., 1998-2000 (Private practice, Casper, WY) Karuna Gaddam, M.D., 1998-2000 (VA Medical Center, Grand Island, NE) Shailaja Veligandla, M.D., 1999-2001 (Private practice, Omaha, NE) Ann Shahwan, M.D., 2000-2002 (Private practice, Woodland Hills, CA) Akhleish Sharma, M.D., 2000-2002 (Faculty, Creighton University School of Medicine, Omaha, NE) Mehmood Nawab, M.D., 2001-2003 (Private practice)
32
GRADUATE STUDENTS AND INFECTIOUS DISEASES DIVISION FELLOWS (Subsequent Position): Bertha Ayi, M.D., 2002-2004 (Private practice, Sioux City, IA) Kirby Slifer, D.O., 2002-2004 (Private practice, Indiana) Mary Ricardo-Dukelow, M.D., 2003-2005, (Research with Dr. Howard Gendelman, UNMC, Omaha, NE) Angela Remington, MD, 2004-2006 (Private practice, Omaha, NE) Hassan Dakroub, MD, 2004-2006 (Private practice) Ahmad Nusair, MD, 2005-2007 (Faculty, Marshall Univ. School of Medicine, Huntington, WV) Carlos Figueroa Castro, MD, 2006-2008, (Private practice, Columbia, MO) Madhu Murthy, MD, 2006-2008 (Private practice, Phoenix, AZ) Trevor Van Schooneveld, MD 2007-2009 (Faculty, University of Nebraska Medical Center, Omaha, NE) Ather Syed, MD, 2007-2009 (Private Practice, Milwaukee, WI) Joong Kwan, MD, 2008-10 (Private Practice, St. Joseph, MO) Brian Gunter, MD, 2008-10 (Private Practice, Miami, FL) Sujatha Nott, MD, 2009-11 (Private Practice, Phoenix, AZ) Ahmed Abualfoul, MD, 2009-11 (Private Practice, Cedar Rapids, IA) Kari Neemann, MD, 2010-12 (Pediatric ID Fellowship, University of Nebraska/Creighton University) Karim Ali, MBBS, 2010-12 (Private Practice, Ontario, Canada) Cezarina Mindru, MD 2011-13 (Faculty, Baylor University School of Medicine, Houston, TX) Renuga Vivekanandan MD 2011-2013 (Faculty, Creighton University School of Medicine, Omaha, NE) Akbar Ali, MD 2012-2014 (Private Practice, Virginia) Leo Dobronski, MD 2013-2015 (Private Practice, Virginia) John Horne, MD 2013-2015 (Faculty, Creighton University School of Medicine, Omaha, NE) Javeria Syed, MD 2014-2015 (Transferred to Wayne State University School of Medicine) Allen Ameri, MD 2015-2017 (Clinical faculty, UCLA School of Medicine, Los Angeles, CA) Manasa Velagapudi, MD 2015-2017 (Faculty, Creighton University School of Medicine, Omaha, NE) Rich Paguia, MD 2016-2018 Michael Petzar, MD 2017-2019 Anum, Abbas, MD 2017-2019